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Abstract 
Chinese Hamster Ovary (CHO) cell is a major manufacturing platform for one of the most 
valuable biopharmaceutical products: monoclonal antibodies. Being an immortal cell line 
adapted to different environments, CHO has been accumulating massive mutations in its 
genome. Continuous effort has been invested into building a computational model to predict 
CHO cell productivity. However, not much attention has been focused on its proteins which 
are surely effected by the mutations accumulated to some extent.  
In this project, we focused on the functional effect caused by non-synonymous variants found 
in CHO genome. A tool was built to firstly identify these variants and then predict their 
potential function effect by preservation, a concept derived from evolutionary conservation. 
Firstly, the PANTHER subfamilies, which defined on the base of potential function change 
within gene trees, were extended by adding proteins from species not covered by PANTHER. 
Sequences within the same subfamily were then aligned and had Hidden Markov Models 
(HMMs) built on these alignments. The HMMs were used to identify homologs in CHO 
proteins. After that preservation were calculated in every site of the alignments, which was 
then used to predict the function alterations caused by mutations on every site.  
Our tool was then validated using data from origin PANTHER subfamilies, PANTHER-PSEP 
which also calculated site preservation and BLAST, a well-accepted homolog searching 
algorithm. CHO protein sequences were then imported and analysed by our tool. For 
comparison, protein sequences from Chinese hamster were also analysed alone with two 
published CHO cell lines: CHO-K1 and CHO-K1GS. The predictions of proteins from these three 
genomes were then compared by mapping onto Gene Ontology (GO). Some detailed case 
studies were also demonstrated. Our tool showed good performance in validations, however, 
they failed to produce useful hypotheses that would motivate further experiments on bench. 
The potential causes are discussed at the end. 
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1 Introduction  
 
1.1 Research background and motivations 
Chinese Hamster Ovary (CHO) cell is a mammalian cell line which has been cultured for more than 
three decades. For different research or manufacturing purposes, it had been adapted to different 
culture environments and therefore derided many descendent cell lines with various characters. 
Some of them were adapted to inorganic environments of cheap, easy-to-control, scalable, massive 
culture for industrial production. One of its most valuable products is the monoclonal antibody 
(mAb), an important compound secreted by the human immune system. In spite of recent recession 
in the pharmaceutical market, the global sale of mAbs and their functional fragment maintains 
stable in its growth. However, the complexity of mAbs also laid down substantial restrictions on 
manufacturing platforms. One of the most significant requirement is human compatible post 
translation modification (PTM). CHO cell as a mammalian cell line inherently shared a big part of 
protein synthesising pathways with humans and therefore, became one of the most promising 
candidates of expression platform. However, expressing exogenetic product brings large stress to 
the cell and the productivity was extremely low at the beginning. After decade’s development on 
both culture process and cell lines, the productivity has been largely improved by tens of times. 
However, most of the improvements were made by process optimisation and the knowledge of CHO 
cell biology remains fairly limited. The first genome of CHO was not made available until 2011 (Xu 
et al., 2011). It came from a CHO cell line parent to many production cell lines: CHO-K1. The 
development of sequencing techniques allow cheap and fast acquirement of genomic data, enabling 
further research on CHO biology. However, processing and interpreting the massive data generated 
by sequencing machine became the bottleneck for current research. 
Bioinformatics is a technique developed for resolving this problem. The CHO industry community is 
longing for a computational model that can predict and improve CHO productivity before the culture 
starts. It requires integration of large amounts of various types of data ranging from nutrition in the 
media to the gene expression in the cell. The first consensus CHO metabolic model was merely 
published in late 2016 (Hefzi et al., 2016). While metabolic flux are extensively modelled, the 
proteins carrying related functions were not getting enough attention. As a cell line being 
engineered for different purposes, mutations are intensively accumulated in CHO genome. It is very 
2 
 
often that these mutations change the function of the CHO proteins, which is also the reason that 
CHO could quickly adapt to major changes in the culturing environment. Given the knowledge of 
how these mutations affect the function of protein related to production process, accurate protein 
efficacy can be predicted for the metabolic model. Also, as genome editing tools, such as CRISPR 
techniques (Sander & Joung, 2014), had been made available, it is possible to optimise cellular 
production process in the molecular level given that knowledge. However, it has rarely been 
explored on CHO. Current use of genome editing techniques, such as CRISPR/CAS9, only focus on 
transgene integration(J. S. Lee et al., 2016) and engineering on glycan profile (Sun et al., 2015). 
The ration between mutations and protein function is mainly studied in the human genome (Wong 
& Zhang, 2014; Zeng et al., 2014; Wu & Jiang, 2013). It is not rare that genetic information is used 
for understanding cancer pathology and predictions of cancer (Shihab et al., 2013; Reva et al., 2011). 
Computational tools had been developed to analyse sequence variant effect on human disease in 
residue level (Wong & Zhang, 2014; Hu et al., 2007). These tools are mostly supported by data from 
clinic researches and all focus on disease related genes in the human genome. Transferring these 
tools on production or metabolism related genes on CHO would need to counter a major challenge 
of lack of supporting data. Additionally, the first draft human genome was published in 2001 (Venter 
et al., 2001), 10 years earlier than CHO. Since then, annotating human genome has been conducted 
intensively by research groups around the world making the human genome one of the best 
understood animal genomes. In comparison, the CHO genome was only assembled in the scaffold 
level and the annotation works have been conducted by the CHO community for a few years. 
In this project, we aimed to develop a tool predicting function impact of sequential variant in CHO 
proteins. As a starting point, we were minimising hypotheses application in our tool to reduce bias 
and allow various hypotheses application in further development. Data from other species, 
especially rodents, would be used to compensate for the lack of data for CHO. To use these data 
from different species, phylogenetic information which is also used by tools predicting human 
diseases, were extensively applied. We identified types of mutations and developed models 
accordingly which would all contribute to the predictions. Related data and tools would be used for 
validation and comparison to evaluate the performance of our tools and finally, hypotheses would 
be made on the generated predictions.    
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1.2 Objectives 
The main target of this project is developing a computational tool that could predict functional 
change of proteins. To achieve this target, it was broken down to several objectives: 
 Identify the most suitable tools and data resource from the related literature. Well-
developed tools should be used as the foundation of our tool. Therefore, performance 
surveys of tools built for different purposes need to be reviewed. The underlying 
assumptions adopted by tools used in our pipeline must not conflict with each other. In 
addition, although large amount of data would be required to generate reliable prediction, 
the data needs to be selected to reduce unnecessary noise in the system. 
 Build the predicting tool (models) using related with minimum assumptions. In this process, 
underlying concepts and assumptions would also be identified. Assumptions should be 
derived from existing assumptions adopted by tools with good performance. Inherent 
limitations should also be identified. 
 Validate the tool with proper data and related tools. Data for validation should be selected 
before the tool was built and isolated from the building process. Inherent difference 
between the tool built in this project and tools used for validation should also be identified 
and standard for evaluating tools should be made clear. Performance and limitation of the 
tool should be examined with the concepts and assumption adopted. Matrices used by the 
tool should also be adjusted in this stage.  
 Apply the tool to CHO proteins and generated hypotheses. Methods of interpreting the 
prediction results into hypotheses should be described. Certain hypotheses should be made 
for comparison with existing knowledge to estimate the quality of other hypotheses made 
for inspiring research.  
 Identify the limitations and potentials of the tools and its resulted hypotheses. Depend on 
the quality of the hypotheses the prediction could provide, assumptions and potential 
improvements of the tool should be discussed. 
It is worth to mention that not all the objectives above were successfully accomplished in this thesis 
but actions or resources required to fully accomplish these objectives will be discussed at the end. 
After all, this project merely set up a starting point for further sophisticated development of models 
which could make significant contribution to CHO cell engineering. 
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1.3 Thesis structure 
Firstly, the research background and knowledge required to understand the rationales of related 
tools is provided by reviewing related literatures. The importance of CHO cell as a manufacturing 
platform and its most valuable product mAbs is highlighted in the literature review. The main 
sequencing platforms are then acknowledged as the source of sequences intensively used in this 
project. Important tools for comparing sequences, calculating phylogenetic distance and topology 
and predicting protein function and structure are then detailed. Lastly in that chapter, databases 
storing and managing related data and relevant research on CHO are briefly introduced.  
After that, a methodology chapter follows with detailed descriptions of the pipeline of the tools, 
accompanied by justifications in every step. An overview of the pipeline is provided at the beginning 
of the chapter. In short, we used Hidden Markov Models (HMMs) to integrate sequential 
information of every homolog groups and identify the best available homolog in CHO. Then site 
conservation was calculated and provided evidence to make predictions on function alteration. The 
detailed description of the step is started from data selection, alignment to phylogenetic tree 
construction and the final HMM construction and conservation calculation. A detailed description 
of external tools used by the pipeline will be provided in the end of the chapter.  
The validation of the built tool is described in chapter 4. As the homolog selection we used were 
mainly derived from PANTHER subfamilies, subfamily members not used for building HMMs were 
used to validate the performance of the HMMs we built. On the other hand, we compared the 
preservation result calculated by another tool with ours. At last, we validated the site preservation 
results with functional site annotations from UniProt. 
In chapter 5, analysis of sequence data of three published CHO related genome using the tool we 
developed is described. We randomly selected prediction results to compare with BLAST results. 
And then we used published CHO expression results to verify a hypothesis we made given the site 
preservation was correctly calculated. Lastly, we compared prediction difference between three 
CHO related genomes by mapping the prediction onto GO. 
Several case studies are described in chapter 6. We studied mutations on TP53 of three CHO related 
genomes. Then we chose glycolytic process, apoptosis, DNA repair and glycosylation to inspect in 
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detail. A discussion of the achievements and limitations of the tool is provided in the final chapter 
with the potential future works. 
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2 Literature Review 
 
In this chapter, background information will be first provided in order to explain the motivations 
and objectives of this project. Then related bioinformatics techniques, tools and databases will be 
introduced, where basic concepts, strategies and algorithms are described briefly suggesting the 
selection of tools in this project. Lastly, CHO related research and the data they generated will be 
reviewed, explaining the challenges and novelty of the works in this thesis. 
 
2.1 Chinese Hamster Ovary Cells 
Despite the recent economic recession the global pharmaceutical market has remained strong 
(EFPIA, 2015), with biopharmaceuticals - drugs manufactured using biological cells - showing 
consistent growth. Including monoclonal antibodies (mAbs), hormones, enzymes, blood-related 
proteins, vaccines, interferons and gene therapy-based products, biopharmaceuticals are used to 
treating conditions such as cancer, haemophilia, diabetes and rheumatoid arthritis. According to 
Walsh (2014), since the first approval of recombinant protein (human insulin) in 1982 there were 
246 biopharmaceuticals approved in the United States and European Union up to 2014. In 2014 
these medications generated sales of $140 billion (Walsh, 2014) and this is projected to maintain 
growth in the near future.  
mAbs are dominant in both sales and sales growth. As shown in Table 2.1, half of the top 10 best-
selling biologics in 2014 are mAbs. Together mAbs accounted for over $40 billion sales in 2013. The 
number one product (Humira), which generated global sales of $10 billion in 2013, has reached a 
20% increase resulting in $12 billion sales in 2014 (Philippidis, 2015). Most of the top-selling mAbs 
were developed by Roche, along with others by AbbVie, Johnson & Johnson, Merck and Gilead 
Sciences. mAbs also accounts for 23% of biologics approved since 1995 (Walsh, 2014). 
mAbs are antibodies secreted by the plasma cell in the immune system that target a specific antigen. 
Licenced therapeutic mAbs are all Immunoglobulin G (IgG), consisting of two heavy chains and two 
light chains, mAb can be divided into three fragments: two Fragment antigen-binding (Fab), 
responsible for specifically binding to the antigen, and one Fragment crystallisable (Fc) that triggers 
downstream immune activities by binding to receptors on the cell surface. Due to the specificity of 
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mAbs they are often designed for cancer treatment (Adams & Weiner, 2005) and autoimmune 
diseases (Feldmann & Maini, 2003). 
 
 
Table 2.1 Top 10 best-selling drugs in 2014 
Data comes from www.genengnews.com 
Name Drug type Sponsor Sale (billion) 
Humira Mab AbbVie $12.543 
Sovaldi Nucleotide analogue Gilead Sciences $10.283 
Remicade Mab J & J and Merck $9.240 
Rituxan Mab Roche (Genentech) and Biogen $8.678 
Enbrel Fusion protein Amgen and Pfizer $8.538 
Lantus Insulin analogue Sanofi $7.279 
Avastin Mab Roche $6.957 
Hercepin Mab Roche $6.793 
Advair Formulation GlaxoSmithKline $6.431 
Crestor Small molecule AstraZeneca and Shionogi $5.869 
  
 
Therapeutic mAbs require an expression platform with proper (specifically, human-like) protein 
folding and post-translation modification mechanisms. Therefore, mammalian cell lines are 
preferable as less genetic engineering is required to reconstruct these mechanisms (that is, they 
natively fold and modify proteins in a human-like manner). Currently, available mammalian 
manufacturing platforms include baby hamster kidney cells, human cell lines Hek 293 and PERC.C6 
(Swiech et al., 2012), and Chinese Hamster Ovary (CHO) cells, which are the most favoured platform 
for mAb production (Wlaschin & Yap, 2007). Up to 2014 35.5% of the total approved 
biopharmaceuticals are manufactured by CHO (Walsh, 2014), including the majority of mAbs and 
some mAb fragments, which account for most of the revenues. Compared to other platforms, which 
only recently succeeded in expressing functional mAbs, CHO has been manufacturing correctly 
folded, glycosylated (in human form) proteins for the past few decades. Apart from the main reason 
of their capacity to correct PTMs, other reasons behind CHO’s popularity include 1) it has been 
proven safe as a medicine manufacturing cell line for over two decades, which makes it easier to be 
approved by drug administration agencies (Kim et al., 2012); 2) it resists most human viruses; 3) it 
can easily adapt to serum-free suspension conditions which allow large scale manufacturing; and 4) 
as a result of 20 years’ optimisation by the biopharma industry, bioprocesses in CHO have been well 
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established. Due to the dominant position in drug production, CHO has become the production cell 
line of greatest interest for industry-related research and manufacturing.  
Most CHO productivity improvements were achieved by optimising culture media and the process 
design (Hacker et al., 2009). Hacker et al. (2009) suggested that further improvements in protein 
yield can be achieved by high throughput transfection and screening. Although large-scale screening 
has been proven effective for obtaining productive clones, it largely relies upon uncontrollable 
factors that could lead to failure when the clones for screening are insufficient. While highly 
productive cell lines were mainly obtained by screening, function manipulation in CHO engineering 
is restricted by a lack of knowledge of the CHO genome’s sequence and organisation. Despite great 
interest in CHO, the first CHO genome was only published a few years ago (Xu et al., 2011). While 
this enabled better understanding both across the whole CHO genome and of its details, allowing 
derived research to thrive in recent years, our knowledge of CHO biology remains relatively limited.  
In contrast, human cancer genomes have been more intensively studied and better understood. 
Although undertaken for totally different purposes, research on human cancer genomes also speaks 
to CHO as CHO shares many genotype and phenotype characteristics with cancers (Lewis et al., 2013; 
Kojima et al., 2009; Tannock & Guttman, 1981). A characteristic shared by all cancer cell lines and 
CHO is genetic instability, which is described as a ‘hallmark of the cancer cell’ by Loeb and Loeb 
(2000). Genetic instability is present at multiple scales, from point mutations through to 
chromosomal aberrations (Roychowdhury & Chinnaiyan, 2016; Weinstein, 2012). It was found long 
ago that most of these mutations are located in non-coding regions (Stoler et al., 1999), but the 
regulation mechanisms of these non-coding regions were only discovered recently and our 
knowledge of these remains limited (Ling et al., 2015). Compared to point mutations, which affect 
only one gene, chromosomal aberration can result in large region rearrangements affecting multiple 
genes. Genetic information, including family history and genome profile, has been used for cancer 
prognosis, diagnosis and treatment response assessment (Roychowdhury & Chinnaiyan, 2016; Ling 
et al., 2015; Weitzel et al., 2011). To acquire related information, systems containing multiple cancer 
cell lines have been set up on different aspects (Barretina et al., 2012; Weinstein, 2012). A series of 
genes have been associated with certain cancers (Weitzel et al., 2011) but surprisingly some 
research has shown that mutated cancer genes are rarely shared even by cancers observed in the 
same organ except TP53 (Podlaha et al., 2012). Cortés and Calvo (2014), however, pointed out that 
the same driver mutations are observed in cancer in different organs and proposed that cancers 
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with the same driver mutations express similar treatment responses. Their findings suggest that 
although universally-shared cancer mutations are extremely rare, certain mutation patterns could 
be found on cancers sharing common drivers. Research effort has also been invested into addressing 
cancer drivers and, more broadly, genetic variances which cause human diseases (Frousios et al., 
2013; Gray et al., 2012). Therefore, while CHO shares many features with cancer cell lines, by 
understanding the common drivers behind CHO we might better comprehend which cancer 
research results are of most relevance. 
 
 
Figure 2.1 Phylogenetic tree of some most widely used CHO cell lines 
The popular CHO cell lines presented are CHO DG44, CHO-K1 and CHO-S which are all 
derived from Chinese hamster separately. (Vishwanathan et al., 2017; Kaas et al., 2015; 
Lewis et al., 2013) The CHO-K1 cell line has been extensively cultured and deriving CHO 
DXB11 and another cell line which then separated into four different cell lines.  
 
While there are many things we might learn about CHO from studying the Chinese hamster genome 
from which it is derived, it is important to note that after decades of engineering and being cultured 
in different environments, the CHO genome should be expected to be substantially different from 
the source organism. Therefore, referencing the host genome (note that the fully assembled 
Chinese hamster genome has not yet been available by the time this thesis is composed) may not 
be as beneficial as in human cancer research. However, compared to large numbers of human 
cancer cell lines, CHO cell lines in use nowadays are derived from only a few ancestor cell lines 
(Figure 2.1), which should have a simpler evolutionary history than cancer cell lines. Therefore, the 
evolution of CHO is easier to track once the cell lines in the lineage are sequenced. Transferring 
methods and concepts from cancer research, certain phenotypes of CHO might be diagnosed. 
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However, being restricted by the data available, information from non-coding regions may not 
support liable diagnosis, while information from coding regions, also known as the exome, could 
provide more supportive results. 
 
2.2 High-throughput Sequencing Techniques 
Genome sequencing was the basis of the genetic analyses mentioned in the previous section. 
Biologists have been trying to sequence DNA since it was found to possess a certain pattern. One of 
the most successful sequencing techniques, developed in 1977, is known as Sanger sequencing 
(Sanger, Nicklen, et al., 1977), which is based upon DNA replication and gel electrophoresis 
techniques. DNA replication techniques synthesise a complementary chain of the template DNA 
chain with DNA polymerase and four basic dNTPs. The concept of Sanger sequencing is to terminate 
the chain extension process of complementary DNA synthesis at certain points using ddNTPs - 
substances that can replace corresponding dNTPs but not accommodate another nucleotide at the 
next position. Controlling the concentration of dNTPs and ddNTPs in a PCR-like process enables the 
synthesis of DNA copies of different lengths (depending upon whether the terminator is 
incorporated or not), which can be separated using gel electrophoresis. Labelling four types of 
ddNTPs with different dyes (now usually fluorescent) then enables direct readout of the sequence 
after separation using imaging techniques. Using Sanger sequencing the first genome, 
bacteriophage phi X 174 genome, was sequenced (Sanger, Air, et al., 1977). Sanger sequencing was 
then improved to increase accuracy and read length, and reduce cost (Shendure & Ji, 2008) before 
being applied in the Human Genome Project (HGP) to sequence an entire human genome. The HGP 
eventually cost 15 years and about three billion dollars with the collaboration of six countries 
(Collins et al., 2003). Despite the cost, Sanger sequencing is still used as a main approach of 
sequencing short DNA fragments due to its high accuracy and read length. 
Genome sequencing required higher throughput to be cost effective. Next generation sequencing 
techniques, now often referred to as High-throughput sequencing (HTS), became the answer. 
Similar to Sanger sequencing, most of the HTS techniques adopt the concept of sequencing by 
synthesis. They achieve high throughput by employing a shotgun strategy to parallelise the 
sequencing process. In a comprehensive review of HTS techniques by Loman et al. (2012) the 
sequencing process was summarised in four steps: fragmentation, tagging, amplification and 
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sequencing. In brief, the target genome is broken down into short fragments that are then 
immobilised separately on a surface where the fragments are amplified and sequenced. The 
sequencing process conducted by HTS is also different from Sanger sequencing. Instead of 
permanently terminating the extension process, reversible terminators (or even no terminator) are 
employed to pause the process after one base being added to the new molecule. Then the added 
base will be readout, via a series of reactions culminating in a fluorescent signal, before the 
extension continues. In practice, the fragmentation and tagging are often finished in usual labs with 
no sequencing machines, and then the samples (usually referred to as libraries) are sent to 
sequencing facilities where amplification and sequencing are performed by experts. The most 
popular HTS platforms include HiSeq/MiSeq from Illumina (Turcatti et al., 2008), 454 series from 
Roche (Margulies et al., 2005) and SOLiD 5500 series from Life Technologies (Shendure, 2005). 
Although similar strategies are applied, different chemistries are employed by different platforms, 
which lead to differences in performance (Table 2.2). HTS technologies have reduced the cost of 
sequencing the human genome to the order of a few thousand dollars (Loman et al., 2012) which 
allows routine whole genome sequencing. Most genomes now available online were sequenced by 
the HTS technologies introduced above (Ellegren, 2014).  
 
Table 2.2 Performance comparison of DNA sequencing technologies. 
Three most widely used high throughput platforms are represented showing 
difference in time length and amount of data generated for each run, error 
rate and length of reads. 
Platform Run time Gb per run Quality Read-length(bp) 
HiSeq 2000/2500 11 days (regular) 600 10-2-10-3 2*100 
454 GS FLX+ 23 hours 0.7 10-3-10-4 700~800 
5500xl SOLiD 8 days 150 10-2-10-3 75+35 
 
 
Not every sequencing technology has been described here since they have not made significant 
contribution to the genome database. For example, another technology known as nanopore 
sequencing, whose commercial product was announced in 2012 (Loman et al., 2012), uses 
transverse tunnelling current to detect nucleobases when the DNA strand is driven through the 
nanopore (Branton et al., 2008). There is no tagging or amplification required for this technology 
and it is found to be able to sequence DNA methylation in current research (Simpson et al., 2017). 
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While the approach holds much promise, it is mentioned only briefly here as it has yet to contribute 
significantly to genome databases. 
 
2.3 Bioinformatics Techniques 
With the capacity to acquire large sequence data sets, annotating and analysing these data becomes 
the next challenge. For related proteins, which is the main focus of this project, most annotation 
and analyses are centred upon their function and structure. Novel functions and structures of 
proteins can be obtained by laboratory experiments, while computational tools can annotate 
proteins without experimental evidence based upon sequential similarity or phylogenetic distance. 
The most popular tools for this will be introduced in this section.  
 
2.3.1 Sequence Alignment 
Building a sequence alignment usually is the first step of computational analysis applied right after 
the sequencing data is obtained. It lays down the foundation for downstream processes such as 
homologue analysis and phylogeny analysis. Therefore, the quality of the alignment would 
profoundly affect the performance of these afterward process. In protein sequence alignment, 
ideally sequences should be aligned on their function carrying structure so that functional 
annotation could propagate through alignments (Aniba et al., 2010; Thompson et al., 1999). Based 
on such goals, some benchmarks created wholly and partly by manual alignment according to 
protein structural information acquired from X-Ray crystallography, such as BAliBASE (Thompson et 
al., 1999), are used as gold standards to test the performance of automatic aligners. Although these 
benchmark databases contain high quality multiple sequence alignments, they are limited in 
alignment number and fail to cover all protein types (Le et al., 2017).  
 
At the very beginning, alignment algorithms were focused upon pairwise alignment. Some classic 
algorithms, such as Needleman-Wunsch (Needleman & Wunsch, 1970) and Smith-Waterman (Smith 
& Waterman, 1981), are still widely used in small scale searching. The most widely used searching 
tool is the Basic Local Alignment Search Tool (BLAST) which has been made available on NCBI and 
Ensembl website. To achieve fast search on large databases, BLAST employs heuristic methods 
wherein short sub-sequences are used instead of full length sequences (Altschul et al., 1990, 1997). 
After decades of development, BLAST was specialised for a variety of purposes such as blastp and 
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blastn (Ye et al., 2012; Morgulis et al., 2008) and a slower but more accurate version, known as 
Position-Specific Iterated BLAST (PSI-BLAST), is also available. 
 
Based on the results of sequence search, more intensive aligning between similar sequences has 
also attracted a great deal of research interest. Specified aligning tools were built to align multiple 
sequences to identify features such as genetic distance and sequence conservation. After decades 
of continuous effort, a great number of multiple sequence aligning tools have been developed for 
accurately aligning multiple sequences at relatively high speed. The most popular aligners include 
CLUSTAL W (Thompson et al., 1994), T-coffee (Notredame et al., 2000), MUSCLE (Edgar, 2004), 
MAFFT (Katoh & Standley, 2013; Katoh et al., 2002) and Probcon (Do et al., 2005). In general, the 
above methods employ the same aligning strategy laid down by Thompson et al. (1994) in the 
development of CLUSTAL W. They firstly calculate the distance between involved sequences, which 
is then used to construct a guide tree. After that, progressive alignment is performed according to 
the guide tree and the alignment is optimised on certain criteria in this process. The main differences 
between these methods are how alignments are evaluated and internal details of the aligning 
algorithms, which result in different alignment accuracy and time cost. By default, CLUSTAL W scores 
the alignments with PAM (Dayhoff & Schwartz, 1978) along with assigning weights to different 
sequences. Higher penalties are assigned when starting a gap while expending the gap costs less in 
scores. T-coffee inherits many features from CLUSTAL W but instead of aligning columns 
indistinguishably, T-coffee uses a library of high confidence short alignments as seeds and aligns the 
whole sequence by extending these seeds. MUSCLE also applies similar features to CLUSTAL but 
jointly improves the guide tree and alignment in a progressive optimisation phase. MAFFT vectorises 
residues on their chemical characters and uses fast Fourier transform to locate homologous regions. 
Lastly, Probcon adopts Hidden Markov Model (HMM) and Bayesian statistics to assess alignments. 
The results are then used to build a guide tree and refine the alignments.  
 
With multiple high performance aligners available, the best of them remains arguable. In general, 
Probcon seems to create more accurate results in some aspects but it is also the most time 
consuming, while MAFFT creates equal or slightly worse results but at a much higher speed 
(Thompson et al., 2011; Blackshields et al., 2006). MAFFT also is one of a few methods that can 
create large alignment with about 10,000 sequence in an acceptable time period (Sievers et al., 
2011). 
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2.3.2 Hidden Markov Models 
Hidden Markov Models (HMM) are an advance version of Markov chain (MC) models. In simple 
words, MC is a model of a sequence of events where the order of events can be varied but the 
selection of the next event is solely dependent upon the current event regardless of the previous 
event sequence. In statistics, MC can be used to calculate the probability of a certain sequence of 
events or the probability of certain events occurring at a certain position of the sequence. One of 
its most important applications in Statistics is Markov Chain Monte Carlo (MCMC), which can be 
used to approximate Bayesian posterior probability when the actual posterior is hard or impossible 
to calculate. In the MCMC process, the concept of MC is only used to generate samples as every 
sample in the process is generated on the base of the previous sample and certain random variables. 
More details of posterior calculation with MCMC will be introduced in the tree construction section. 
 
Based on the MC model, Hidden Markov Model (HMM), was developed. Similar to the MC, HMM 
describes an event sequence. However, in HMM the true events cannot be directly or completely 
observed and therefore are considered hidden. The hidden event sequence can be estimated by the 
observed sequence it derives. Similar to MC, algorithms, such as forward and backward algorithm, 
have been developed to calculate the probability of certain hidden sequence and certain events in 
the sequence. In bioinformatics, profile HMM (Eddy, 1998) was developed to describe the profile of 
given multiple sequence alignment. In profile HMM, the possible residue distribution of each 
position can be observed while the biological or statistical content of the position is considered 
hidden (Eddy, 2004). To enable easy application of profile HMM, HMMer (Eddy, 1998, 2011; Finn et 
al., 2011) was developed. HMMer is a package of basic HMM tools including building HMM given a 
sequence alignment, searching sequences using a profile HMM, searching profile HMMs with a 
given HMM and alignment sequences according to given HMM. Based on the profile HMM, more 
tools have been developed for other purposes, such as HHalign (Söding, 2005) adopted by Clustal 
Omega(Sievers et al., 2011) which aligns distant homologues by aligning their profile HMM, and 
ProbCons (Do et al., 2005) which employs HMM to create accurate multiple sequence alignments. 
HMM is able to capture features of a given sequence groups and provides high sensitivity sequence 
search. This allows databases based upon HMM to be built for protein families and conserved 
domains. Popular, HMM-based databases include PANTHER (Mi et al., 2016), which focuses upon 
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functionally-related subfamilies and has been adopted by Ensembl (Yates et al., 2015), and Pfam 
(Finn et al., 2016) which is a UniProt (Bateman et al., 2017) member database focusing upon protein 
domains. Recently, HMM was even used to detect DNA methylation with nanopore sequencing 
(Simpson et al., 2017). 
 
2.3.3 Phylogenetic Tree Construction 
Phylogenetic tree construction is another important part of bioinformatics that forms the 
foundation of much biological research. Understanding the evolutionary history of genes and 
species can provide evidence for genetic and taxonomic research. Based upon sequence alignment, 
the genetic distance between two genes, which is often defined as the minimum number of edits 
required to transform one gene into another, can be assessed. However, errors could be introduced 
by many factors such as: incorrect alignment, incomplete search of possible tree topology and 
incomplete lineage sorting (ILS) (Figure 2.2) (Noutahi et al., 2016a; Mirarab et al., 2016; Boussau et 
al., 2013), which make constructing accurate trees a challenge. 
 
The unweighted pair-group method based upon arithmetic averages (UPGMA) (Sneath & Sokal, 
1973) and Neighbour Joining (NJ) (Nei et al., 1987) are two of the most widely used tree building 
methods. They both build binary trees by combining genetically close homologues. Where UPGMA 
assigns equal distance between the ancestral node and its two offspring as a simplification, NJ 
assigns a more accurate branch length. However, the simple assumptions they rely upon - that the 
edit distance between sequences is proportional to their genetic distance - does not include the fact 
that the evolution rate varies over different times and species. Despite it being well acknowledged 
that their performance highly depends upon the order of the input sequences, meaning that 
multiple topologies may be created from the same data depending upon the order in which they 
are presented (Backeljau et al., 1996), they are still used by many software, such as CLUSTAL (Higgins 
& Sharp, 1988), to create draft trees. By adopting parsimony methods, they are able to construct 
trees on a small amount of data with high speed, but they lack the ability to examine and optimise 
the accuracy of the trees.  
 
In order to build optimised and accurate trees on large data, more advanced methods have been 
developed, of which the most accurate ones are likelihood based methods adopting Maximum 
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Likelihood (ML) (Felsenstein, 1981) or Bayesian approaches (Yang & Rannala, 1997; Rannala & Yang, 
1996). The most popular methods includes RaxML (Stamatakis, 2014), PhyML (Guindon et al., 2010; 
Guindon & Gascuel, 2003), MrBayes (Ronquist et al., 2012) and PhyloBayes (Lartillot et al., 2009).  
 
The likelihood of a phylogenetic tree is the product of the likelihood of the branches, which in turn 
are calculated based upon substitution models. Similar to substitution matrixes such as PAM 
(Dayhoff & Schwartz, 1978) and BLOSUM (Henikoff & Henikoff, 1992), substitution models describe 
the substitution rate between nucleotides or amino residues but more parameters may be involved 
apart from log-odds scores. Such likelihood has been used as a standard to find the best tree, which 
has yielded promising results, but the high cost of the required processing power is a drawback 
(Guindon et al., 2010; Stamatakis et al., 2005; Holder & Lewis, 2003). Additionally, exhaustively 
searching all possible trees for the best tree is only possible for small amount of data and therefore 
heuristic searching must be used in most cases. The strategy of achieving the best tree with heuristic 
methods, which is often described as hill-climbing, involves altering the tree with the current best 
likelihood until no further improvement on likelihood can be made. The confidence of the tree is 
then assessed by bootstrapping how well the observed data supports the mooted tree by 
resampling the sequences (and replacing sequences generated from the observed alignment) to 
reconstruct the same tree. Such a process brings an extremely heavy computational burden since 
the iterating likelihood calculation for the tree search would be conducted after each bootstrapping 
which in turn repeat multiple times. Note that bootstrap scores only show the likelihood that the 
same result can be acquired when more data is imported, but not the accuracy of the result (Alfaro 
et al., 2003; Holder & Lewis, 2003). Software adopting ML such as RaxML and PhyML have 
significantly improved the speed of the integrated process but intensive computation is still required 
for large families. For example, analysing a 16S dataset of nearly 28,000 sequence with RaxML 
requires more than 1,200 hours (K. Liu et al., 2011).  
 
Bayesian inference uses posterior probability that correlates with likelihood to evaluate trees. 
According to the hypothesis made, posterior probability can involve parameters not included by 
traditional likelihood calculations, which increases the flexibility of the Bayesian approach (Holder 
& Lewis, 2003). A form of posterior probability that only involves substitutions in sequence 
alignments, substitution models and the tree branch length was described by Huelsenbeck and 
Ronquist (2001). However, the authors also pointed out that analytically calculating the posterior 
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probability is too complicated to achieve. Therefore, Markov chain Monte Carlo (MCMC) method is 
used to achieve the approximate posterior. The general idea of using MCMC is to randomly explore 
the space of all trees step by step using certain criteria, such as change of likelihood or prior between 
current step and the next step (Huelsenbeck & Ronquist, 2001), using a random variable to decide 
the next move. A conceptual chain is then formed by these steps as they tend to stay in certain 
regions (of high likelihood if increase of likelihood is used as moving criterion) of the space. The ratio 
of steps in the region to total steps can be used as a valid approximation of the posterior probability. 
Different models and hypotheses have been proposed and the calculation has been optimised for 
higher speed on tools such as MrBayes and PhyloBayes. Note that MCMC would create many more 
trees than bootstrapping but each tree bootstrapping created requires tree search which could test 
many trees before the final and each tree in MCMC process is created under certain restrictions by 
random. Therefore, the MCMC process may be faster than bootstrapping in some situations. 
Greater comparison of bootstrapping and MCMC is discussed by Alfaro et al. (2003) and Holder & 
Lewis (2003). 
 
The methods described above mainly account for substitutions between sequences. However, 
current research shows that the information contained by the sequences is insufficient for 
constructing accurate trees and reconciliation with certain additional information, such as 
taxonomic trees, which could significantly improve accuracy (Noutahi et al., 2016a; Boussau et al., 
2013; Nguyen et al., 2013; Akerborg et al., 2009). Note that combining information from gene trees 
and species trees invokes a circular problem as the construction of accurate species trees depends 
upon multiple accurate gene trees, whose reconstruction requires reference from species tree 
(Szöllosi et al., 2013; Boussau & Daubin, 2010). Boussau and Daubin (2010) suggested joint inference 
as a solution to the problem. However, while species trees need to be first constructed as reference, 
arguments are raised between two conflicting species tree constructing approaches: concatenation 
and coalescence. While concatenation considers the gene tree and species tree to be identical, 
coalescence takes incongruence between the gene tree and species tree (Figure 2.2), which is well 
known (Maddison, 1997), into consideration. Maddison (1997) summarised the biological causes of 
the discord between gene phylogeny and species phylogeny. These biological events lead to ILS, 
where some alleles fail to present in certain lineages, which in turn leads to an important error in 
concatenation trees. Therefore, there is an increasing preference for using coalescence methods 
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(Simmons & Gatesy, 2015; Liu et al., 2009) although some research shows that both approaches 
result in statistically equivalent accuracy (Tonini et al., 2015; Warnow, 2015).  
 
 
Figure 2.2 Incongruence between gene tree and species tree and ILS 
An example of incongruence of gene tree and species tree is shown in a. The species trees 
are presented in blue bars and the gene trees are presented in black lines. The ILS that 
could cause such incongruence is illustrated in b. Red lines with dots at the end represent 
genes missed by sequencing or annotation. Losing these genes represented by red lines can 
also lead to the same incongruence.  
 
 
Different methods have been developed for reconciliation between a species tree and gene tree to 
create a more accurate gene tree. In general, they focus on modelling evolutional events including 
duplication, loss, transfer (Boussau et al., 2013; Szöllosi et al., 2013; Rasmussen & Kellis, 2011; 
Akerborg et al., 2009) and occasionally speciation (Nguyen et al., 2013). The benefits to gene 
function inference of analysing these evolutionary events have been recognised by researchers 
(Blackstone, 2006; Eisen, 1998). While most methods focus upon gene trees, some of the methods, 
such as PHYLDOG (Boussau et al., 2013), also reconstruct a species tree when correcting gene trees. 
Bayesian approaches and MCMC are used to calculate likelihood or related posterior in these 
methods. Although these methods are able to increase the gene tree accuracy, the main drawback 
that most suffer are intensive computation and overfitting to the species tree (Noutahi et al., 2016a; 
Wu et al., 2013). 
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2.3.4 Protein Structure Prediction 
It is common knowledge that certain protein structure is required for its function. Proteins with 
distorted structure, mostly due to incorrect folding, would be actively disassembled. The number of 
protein structures increased with the number of sequenced proteins, but still only a very small 
proportion of proteins have experimental structures (Moult et al., 2014). It is believed that the 
protein sequence alone contains enough information to determine the three-dimensional structure 
(Marks et al., 2012). Therefore, computational prediction of protein structure based upon sequence 
could potentially fill the gap. However, it has been a major challenge for more than four decades 
(Marks et al., 2012). 
To facilitate better development of predictive models, the Critical Assessment of methods of protein 
Structure Prediction (CASP) tournament has been held to evaluate predictive models (Moult et al., 
2014). According to CASP, there are two types of predictive models: template-based models (TBM) 
and free models (FM). TBM compares query sequence to (homologous) sequences with known 
structure and generates structure prediction by refining the known structure. In contract, FM 
usually predicts structure ab initio, although distant related templates may be used (Tai et al., 2014). 
Some predictors adopt both types of modelling, finding closely related templates or constructing 
novel structures when templates fail. The best predictive tools suggested by CASP include QUARK 
(Xu & Zhang, 2012, 2013), I-TASSER (Roy et al., 2010) and Phyre (Kelley & Sternberg, 2009).  
In most cases, TBM achieves better accuracy than FM when available (Huang et al., 2014; Tai et al., 
2014). Predictors with TBM are mostly based upon recursive improvement of profile alignments, 
where profiles can be in different forms such as position-specific scoring matrix (PSSM) and HMM. 
The modelling accuracy has largely improved in the last two decades, but only in relatively few cases 
can an accurate prediction be obtained (Moult et al., 2014). One consequence of the difficulty of 
predicting structure from sequence is that it remains very common to predict protein function 
directly from sequence without referencing the protein structure. 
 
2.3.5 Non-synonymous Nucleotide Variant Impact 
It is clear that changing protein structure can change function but the function could also be largely 
affected by the change of a few residues. Such changes are caused by non-synonymous Single 
Nucleotide Variant (nsSNV), which are also referred to as non-synonymous Single Nucleotide 
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Polymorphisms (nsSNPs) in some cases. These have attracted particular interest especially in the 
field of human disease. Experimentally these nsSNV can only be examined with very low throughput. 
Therefore, computational methods have been developed to predict the functional impact of these 
nsSNVs. The best predictors nowadays rely upon information such as phylogenetic conservation, 3D 
protein structure and chemical character of the residues. Protein structure could provide useful 
information for predicting nsSNV impact on protein function. For example, a nsSNV at the 
interaction site on a protein surface would significantly change the protein function (David et al., 
2012). The most popular predictors include SIFT (Kumar et al., 2009), PolyPhen 2 (Adzhubei et al., 
2010), PANTHER-PSEC (Thomas & Kejariwal, 2004; Thomas et al., 2003), PROVEAN (Choi et al., 2012), 
MutationAssessor (Reva et al., 2011), MutationTaster (Schwarz et al., 2010) and Condel (González-
Pérez & López-Bigas, 2011). These are mostly focusing on predicting deleterious impact in human 
diseases. In general, these predictors can be divided into three types: 1) predictors based on certain 
model and hypotheses, mainly of genetic conservation and protein structure, such as SIFT, 
PANTHER-PSEC, PROVEAN and MutationAssessor; 2) predictors collecting various types of features 
and adopting machine learning classification methods such as naïve Bayes and random forest to 
make predictions, such as MutationTaster; 3) consensus predictors which summarise predictions of 
other predictors (usually predictors of first type) to generate their own predictions, such as Condel 
which integrates five other predictors including SIFT, PolyPhen2 and MutationAssessor. The last two 
types often include features involved by the multiple predictors in the first type. However, 
consensus predictors often generate integration scores using scores from other predictors with 
certain algorithms, while machine learning predictors assign different weight to the features 
depending on the training data, which means the same feature may be assigned different weight 
according to the training set. 
The consensus predictors appear to outperform other predictors in performance surveys (Frousios 
et al., 2013; Gray et al., 2012) by taking advantage of including multiple features and hypotheses. In 
fact, features and hypotheses on multiple aspects enable machine learning based predictors to 
generate improved results (Wong & Zhang, 2014; Zeng et al., 2014). However, no single predictor 
generally outperforms others (Katsonis et al., 2014). Currently, Grimm et al. (2015) pointed out two 
circularities that could lead to erroneous conclusions on performance comparisons mentioned 
above. These circularities are caused by the fact that these predictors were trained and compared 
upon overlapping data sets and variants of the same genes are jointly labelled in variant databases. 
Based on that, Grimm et al. (2015) proposed using a subset of SwissVar to evaluate predictor 
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performance. In addition, Katsonis et al. (2014) suggested selection of predictors could be based 
not only on accuracy but also the hypotheses or features adopted.  
Although structure information is useful for estimating the functional impact of a single residue 
change, using protein structure only is not practical since the structural information is not available 
for most proteins and the alternative way to access structure information, via structure predicting 
tools, is limited by accuracy. Also, a low number of nsSNVs are not likely to significantly change the 
protein structure and addressing interaction sites can be achieved by sequence alignments or HMMs 
with homologous annotation. Therefore, protein structure predictors are mostly unnecessary in 
estimating such functional impact. 
  
 
2.4 Important Databases 
To effectively make use of biological data and related annotations, sophisticated management of 
these information is required. Multiple databases were built and maintained by specialised 
institutes to facilitate the collection, storage and delivery of various types of biological data. 
Databases storing gene and protein related information were involved in this project and therefore 
reviewed in this section. 
 
2.4.1 Gene databases 
Genome sequences are commonly used as the base of molecular biology research. To keep these 
data up to date and available globally, three databases - GenBank built by the National Center of 
Biotechnology Information (NCBI), European Nucleotide Archive (ENA) operated by European 
Molecular Biology Laboratory (EMBL) and the DNA Data Bank of Japan (DDBJ) - collaborate with 
each other as partners of the International Nucleotide Sequence DataBase Collaboration (INSCO), 
exchanging data daily to maintain information consistency (Clark et al., 2015). Current sequencing 
techniques are not able to sequence genomes or chromosomes in the whole. The genome or 
chromosome sequence is obtained by sequencing fragmented nucleotide pieces then assembling 
these pieces with computational techniques. However, such a strategy is problematic in handling 
repeat content and duplicate regions in practice as assembling tools often fail to distinguish short 
reads from different copies. Pair-end sequencing techniques could help to improve the assembly 
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but still fail to bridge the entire duplication area (Alkan et al., 2011). Alkan et al. (2011) found 
substantial loss of these regions on genomes created solely by assembling short read generated by 
current high-throughput sequencing. Their research shows 93% of the exons were completely 
recovered while 43.7% of genes were underrepresented. Genome Reference Consortium improves 
the genome assembly using high-quality long sequences. However, they only work on a few 
genomes including two mammalian species: human and mouse.  
Basing on specific genome assembly, annotations then can be made. Consisting of more than 
340,000 species, GenBank also contains the corresponding annotations, which can be supplied by 
the authors who generate the sequence or the annotation pipeline provided by the manage 
institutes. Quality annotations are crucial for making use of the sequence data and can be generated 
in different ways with different quality and redundancy. NCBI initiated the Reference Sequence 
(RefSeq) project to collect and integrate such published annotations (Pruitt et al., 2014), while EMBL 
established Ensembl together with the Wellcome Trust Sanger Institute for the same purpose (Yates 
et al., 2015). Similarly, the annotation pipelines they provide rely on supporting evidence such as 
cDNA libraries, protein sequences and RNA-seq data. For annotating newly sequencing genomes 
which lack supporting data, sequences from related organisms will be used as reference. On this 
process, the annotation of existing sequence would transfer to newly discovered gene based on 
their sequential similarity. The annotations made by these pipelines include identifying open 
reading frames (ORFs), introns and exon and splice variances, homologous grouping and function 
inference based on homologue and assigning IDs to genes and proteins. One of the differences 
between the pipelines provided by NCBI and Ensembl is that the NCBI pipeline is more likely to 
create ab initio gene models when the supporting data is insufficient. Cross reference of external 
databases such as PDB and GO will be made when available. Sequence search and aligning tools are 
also available on their websites for easy access and comparison of interested data.  
 
2.4.2 Single Nucleotide Variation (SNV) databases  
SNV is frequently observed throughout the entire genome. It had been associated with human 
diseases and become a research hot spot of bioinformatics application in medicine (Ling et al., 2015; 
Cline & Karchin, 2011). Up until December 2017, data of 55,707 unique SNVs (referred as Single 
Nucleotide Polymorphisms, SNPs) had been collected by Genome-wide association studies (GWAS 
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http://www.ebi.ac.uk/gwas/home). Although SNVs in non-coding regions have been found to 
significantly contribute to disease in the last decade (Ling et al., 2015), most of the works have been 
focusing on SNVs on coding regions that change the protein sequence since it is believed that these 
non-synonymous SNVs (nsSNVs) are the major contributor (X. Liu et al., 2011). In some works, nsSNV 
is more often referred to as non-synonymous SNP (nsSNP). The main databases storing nsSNV data 
are: the Online Mendelian Inheritance in Man (OMIM) database (Hamosh, 2004), the Human Gene 
Mutation Database (HGMD) (Stenson et al., 2009) and the UniProt database (The UniProt 
Consortium, 2014). While OMIM and HGMD focus on deleterious nsSNVs, UniProt preserves both 
neutral and deleterious nsSNVs and therefore was used for training tools that are developed for 
predicting function impact of nsSNVs. For training purposes, neutral and deleterious SNV sets are 
often separated from databases mentioned above. For example, HumVar and HumDiv, were 
extracted from UniProt and specialised as neutral set and deleterious set respectively (Adzhubei et 
al., 2010). Among these specialised data sets, Grimm et al. (2015) showed that a unique subset of 
SwissVar (Mottaz et al., 2010), known as SwissVarSeleted is the most appropriate data set for 
comparing performance of the deleterious SNV predicting tools (Tang & Thomas, 2016). There are 
also database specified for results generated by popular predictors, instead of experiment proven 
results, for further research on potential candidates, such as dbNSFP (Liu et al., 2013). 
 
2.4.3 Protein databases 
Proteins are the gene product that facilitates most of the biological activities. In eukaryotic cells, 
one gene may encode more than one protein due to splicing, therefore the number of proteins in 
an eukaryotic cell could be much more than the number of genes. Compared to DNA, whose 
function mainly relies on the codes and subtle changes of certain nucleotides, proteins require 
certain three-dimensional structure and post-translational modifications (PTMs) to enact their 
functions. Accordingly, annotations stored by protein database involve more aspects than that of 
DNA. A summary database for proteins - Universal Protein Resource (UniProt) – contains the best 
available resources of these annotations. UniProt is maintained by the UniProt Consortium of three 
partners: European Bioinformatics Institute (EBI), the Swiss Institute of Bioinformatics (SIB) and the 
Protein Information Resource (PIR). It consists of four databases: the UniProt Knowledgebase 
(UniProtKB), which will be the focus of this review; the UniProt Archive (UniParc); the UniProt 
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Reference Cluster (UniRef); and the UniProt Metagenomic and Environmental Sequence (UniMES) 
database (Apweiler et al., 2014). In short, UniProt is a high quality collection of all protein-related 
data that has been well organised for easy comprehension (The UniProt Consortium, 2014). Detailed 
annotations collected by UniProt include not only the basic sequence, family, function and 
homologue, but also PTM, sequence variance, mutation, expression, structure, cellular location, 
protein-protein interaction and related pathology. Manual curation is heavily involved in order to 
maintain the high quality and up-to-date aspect of the annotation. The manual curation is made on 
the experimental evidence together with structural information. Cross reference is also made with 
multiple databases including Protein Data Bank (PDB), Protein Annotation Through Evolutionary 
Relationship (PANTHER), Interpro and Pfam.  
PDB is a protein structure database focusing on collecting, annotating and distributing three-
dimensional coordinate data of protein structures obtained mainly from x-ray crystallography, 
nuclear magnetic resonance (NMR) and electron microscopy techniques. Along with the structures 
of proteins, information on ligands, binding sites and protein-protein interactions are also stored in 
PDB. Structure alignment tools are available on PDB for structure comparison and searching (Rose 
et al., 2013). PDB is intensively referenced by UniProt in terms of protein structure and manual 
curation. Pfam is a database of protein domain families. It consists of a collection of high quality 
models of protein domains (Sonnhammer et al., 1997). The foundation of Pfam is a huge number of 
profile HMM built upon multiple protein sequence alignments. Manual curation is applied to 
maintain the quality of the profile HMM conserved. Profile HMM built on alignments without 
curation were only generated after Pfam 29.0 and they do not represent potential domains (Finn et 
al., 2016). The manually curated Pfam domain annotation is one of the main sources referenced by 
Interpro. InterPro is a database of protein and domain families. Instead of using genetic distance 
like ordinary databases, it integrates information, which is termed signatures, including profile 
HMMs, position-specific score matrices (PSSM) and regular expression to classify proteins into 
families which allows prediction of domains and sites (Finn et al., 2017). To collect signature 
information, InterPro has extended its consortium from four databases to fourteen up to 2016 (Finn 
et al., 2017; Mitchell et al., 2014). Apart from protein search for the domains and site it contains, 
InterPro allows searching domain for proteins it composes. PANTHER is another database 
intensively referenced by InterPro. However, instead of focusing on domains and sites, PANTHER 
relies on traditional phylogeny-base protein classification to infer protein function. The protein 
phylogenetic trees preserved by PANTHER were constructed with reconciliation of species 
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phylogeny with GIGA (Thomas, 2010) to capture evolution events that may lead to function 
deviation such as duplication and transfer (Mi et al., 2016). Subfamilies were then defined according 
to these evolution events and manually reviewed. Ideally, members within the same subfamily 
should share the same function which is significantly different from other subfamilies within the 
family. Profile HMMs were built on every protein family and subfamily to provide predictions for 
query sequences. In addition, Gene Ontology (GO) enrichment analysis is also made available on 
PANTHER website. Recently, PANTHER-PSEP (position-specific evolutionary preservation) was 
introduced for predicting the potential function impact cause by non-synonymous single nucleotide 
variants based on its phylogenetic position (Tang & Thomas, 2016). 
 
2.4.4 Function and pathway databases 
As the number of sequenced genes increases, the amount of function annotation follows. 
Systematic organisation of annotated function is required for easy access and systematic analyses. 
Classification by function characters and by pathways are the most popular systems. As function 
characters can be set in arbitrary manners, classification on such base is highly flexible and able to 
easily achieve high coverage of known genes. A popular example is Gene Ontology (GO) which 
classifies functions into three main aspects. In contrast, classification on pathways is more centred 
on the nature of biological activities and able to present clearer pattern of the interaction network. 
However, it requires a high level of annotation on individual genes, which becomes the main 
restriction from including a large number of genes. Well known examples of such systems are the 
KEGG pathway and Reactome databases. 
GO organises biological annotations with a tree-base system in three different aspects: molecular 
function, biological process and cellular component, which are the three ontologies in GO (Harris et 
al., 2004). Genes (or gene products) are attached to the tree through GO terms, which are certain 
biological concepts, and in turn every GO term is attached to their parent terms until the root of the 
tree. All GO terms are ultimately rooted on one of the three parent ontologies being the three 
aspects mentioned above. The backbone relation between these terms is “is a” relation, but other 
relations such as “part of”, “regulate” and “localized to” are also included. The quality of annotations 
and the accuracy of their relations are crucial. Therefore, similar to other high quality databases, 
manually creating high quality annotations from literatures is one of the main missions of GO (The 
Gene Ontology Consortium, 2013). Up to September 2014, 391,174 manually annotated genes and 
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gene products had been created in GO and the total number of annotations had reached 4,185,478 
converged on 41,775 GO term covering 461,573 species (Blake et al., 2015). Although a large 
number of manual annotations had been made, the corresponding proportion remained low. The 
overall annotation quality is continually improved by cross-referencing and collaborating with many 
other databases such as PANTHER and UniProtKB. Tools such as AmiGo and GO slims are developed 
for easy use of GO data. 
Kyoto Encyclopaedia of Genes and Genomes (KEGG) is a resource integrating information about 
genomes, biological systems, medicine and biochemistry on 15 main databases, of which 13 are 
entirely manually created by KEGG and the other two are created combining external databases 
with KEGG annotations (Kanehisa et al., 2012). The main focus of KEGG is the molecular network 
and pathway maps, which are manually generated diagrams containing rich information from 
experimental results about molecular interactions, reactions and locations. Mapping tools are also 
provided for mapping genes to the pathway and mapping transcripts abundance to analyse 
expression levels in the pathway context. The Colour Pathway tool in KEGG can present gene related 
values, such as expression levels, on top of the pathway diagram (Kanehisa et al., 2012). KEGG 
Pathway has been widely used in pathway level studies. 
Similar to KEGG pathway, Reactome is another molecular reaction knowledge base. Compared to 
KEGG pathway, which is more metabolism orientated (Kanehisa et al., 2014), Reactome made 
efforts to cover both metabolic and signalling pathways. Most of the manual efforts were invested 
in human pathways, especially disease related pathways whose mutated forms are also covered by 
Reactome, while pathways from other species are inferred automatically from their human 
counterparts (Croft et al., 2014). In a recent update (Fabregat et al., 2015), the pathway browser 
has gone through significant changes to allow more interactive navigation. By referencing GO, the 
Reactome pathways are organised in a hierarchical structure derived from the biological process 
ontology. Compared to KEGG, Reactome offers a more interactive interface for pathway navigation 
and transcriptomic data of expression levels in different tissues are also presented if available. 
 
2.5 Related Data Resource and Researches on CHO 
CHO, as a cell line is widely utilised in mammalian cell biology research and biopharmaceutical 
manufacturing, it has drawn much interest from researchers in different fields. Many attempts at 
unveiling CHO cell biology profile have been performed before the CHO genome was sequenced. 
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However, not until the year 2011, when the first CHO genome was published by Xu et al. (2011), did 
most of the large-scale surveys become possible. To integrate CHO data resources in various 
perspectives, a Chinese hamster specific database, chogenome.org (Kremkow et al., 2015), was 
created. Up to the year this thesis is written (2017), four CHO related genomes were made available 
on NCBI: a CHO-K1 genome submitted by Xu et al. (2011), a CHO-K1GS genome submitted by Eagle 
Genomics Ltd and two Chinese hamster genomes submitted by Lewis et al. (2013) and Brinkrolf et 
al. (2013) respectively. Only the first CHO-K1 genome and the first Chinese Hamster genome, which 
both have accompanied transcriptomes reference, have been annotated by RefSeq and others were 
used to improve the annotation by NCBI. Annotation of the assembly of CHO-K1 was also performed 
by Ensembl, but the gene count on RefSeq annotation was different from that of the Ensembl 
version. Another annotation was done on the CHO-K1GS provided by Horizon Eagle and is available 
on Ensembl. Lewis et al. (2013) and Kaas et al. (2015) also conducted whole genome sequencing on 
CHO cell lines other than CHO-K1. However, these data are not available on public databases such 
as NCBI. Recently, the mitochondrial genome was intensively sequenced in multiple CHO cell lines 
to deepen understanding of the CHO energy metabolism (Kelly et al., 2017). The four CHO related 
genomes stored by NCBI are only assembled to scaffold level. Despite efforts of creating 
chromosomal map (Lewis et al., 2013; Brinkrolf et al., 2013; Xu et al., 2011), more evidence is 
required to order and orientate scaffolds to form chromosome map for Chinese Hamster or CHO. 
NCBI also continually improves the assemblies of these three genomes and integrates them into two 
reference assemblies, which are available on their ftp site, for Chinese Hamster and CHO-K1 
respectively. Le et al. (2015) compared the RefSeq genomes released in 2012 and 2014 and the later 
shows significant improvement, indicating the importance of resequencing CHO related genomes.  
Multiple sets of CHO related transcriptomics data are also available on NCBI. Compared to genomics 
data, expression data can be obtained not just by high-throughput sequencing but also by 
microarray. Up until 2017, 11 sets of expression profiling microarray data and five sets high 
throughput sequencing data had been made available in Gene Expression Omnibus (GEO) database 
on NCBI. Not all of this data was generated on CHO cell lines, for example, seven of the series were 
generated on hybrid cell lines which are also widely used in manufacturing.  
 
Most of the research on CHO focuses on protein production processes: transgene expression, 
metabolism and protein secretion (Hefzi et al., 2016). To analyse and model these processes 
required input of transcriptome and metabolome. Some of the transcriptomic data was generated, 
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mostly with microarrays, even before the CHO genome was published. Full transcriptomic profile 
analyses were conducted on CHO cell lines at different growth rates (Doolan et al., 2013), in 
response to butyrate (De Leon Gatti et al., 2007), and at low temperature treatments (Kantardjieff 
et al., 2010) to understand cell metabolism in various environments. More broadly, transcriptomic 
data also supports specific interests focused upon miRNA (Hernández Bort et al., 2012) and product 
genes amplification (Vishwanathan et al., 2014). High throughput RNA sequencing was used more 
often after the first CHO genome. Multiple transcriptomic data have been generated on different 
CHO cell lines and different conditions to support research from different perspectives. Rupp et al. 
(2014) developed tools for integrating RNA-Seq data generated by different platforms to enable the 
reusing of this data for different purposes.  
Another computational tool widely used to analyse CHO metabolism is flux models. Combining the 
genome and the metabolome could provide a systematic view of the metabolic network, upon 
which flux models can be built to predict the phenotype with metabolic flux analysis (MFA) and flux 
balance analysis (FBA) (Chen et al., 2012; Ahn & Antoniewicz, 2011; Goudar et al., 2010). These 
models are mostly focused on core metabolism and derive from models built for mice, so that they 
only partly cover the protein production process for CHO. Models that could accelerate cell 
engineering, clone selection and help optimise bioprocesses require genome scale multivariate 
input. Genome scale metabolic models have been proposed (Popp et al., 2016) and recently Hefzi 
et al. (2016) integrated models and data from different group and successfully constructed a 
consensus model for CHO accompanied by serval models specialised for widely used cell lines. They 
reported that the consensus model is able to predict metabolic features of CHO. The construction 
of these models is made possible by the availability of CHO related genomes and the transcriptome 
and proteome data derided from them. 
As the CHO specific model being available, bioinformatics research on CHO could focus on improving 
the existing model by providing detailed information. While the genome-scale metabolic CHO model 
covers multi-omics of CHO, properly analysing the related data with statistic method and integrating 
the results to improve the metabolic model could be one of the main aspects of CHO related 
bioinformatics research. Although significant improvements have been made, a big part of CHO 
metabolism, particularly the regulation mechanisms, remain unknown. Combining high-throughput 
experiments and bioinformatics techniques would provide useful tools to reveal these unresolved 
parts so that more accurate models can be built.   
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3 Methodology 
In this chapter, the analysis pipeline will be introduced followed by detailed descriptions and 
rationales of every step. Important concepts and criteria will be described with the steps involved. 
Lastly, the algorithms and detail settings of external tools will be described.  
The main task of this project is to develop computational tools that could identify proteins with 
altered functions. The related functions and proteins, which will be referred to as defective or 
altered according to likelihood of significant alteration in this work, are considered to either have 
completely lost function or suffered mutations that change their wildtype function and biological 
efficacy. We only investigate mutations within coding areas as proteins are the main operators of 
biological activities. Although non-coding regions have been found responsible for regulation, 
identifying functional impacts on mutations on these regions is limited by the knowledge of 
regulatory mechanisms. In addiction, as the CHO genome at this stage is mostly generated by short 
read sequencing techniques and not yet fully assembled, genes are likely to be underrepresented, 
while the coding region (exons to be more precise) are more likely to be completely recovered 
(Alkan et al., 2011). Protein mutations with functional impacts were divided into two types: 1) 
mutations such as truncation and chromosomal aberration affecting large portions of the protein 
sequence, and 2) mutations such as SNV affecting only a small part of the sequences. 
Correspondingly, two strategies were used for different types of mutations: HMMs for detecting 
large area mutations, and site analysis for spotting mutations at important sites. HMMs were only 
used to generate global scores for the entire protein, while site analysis was used only for scoring 
locally for single sites. In effect, HMMs capture function-related patterns from sequence alignments 
and site analysis captures evolutionary history of each column of the alignment. Both of these 
strategies rely on sequence alignments and phylogenetic information of the target protein families. 
Therefore, a series of publicly available tools were used to construct alignments and phylogenetic 
trees in optimised settings. The general process is shown in Figure 3.1. 
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Figure 3.1 Flow chart of building the function predicting tool. 
Firstly, homologous sequences from PANTHER and Ensembl were aligned. Phylogenetic 
gene trees were then built on these alignment referencing the species tree retrieved from 
Ensembl. According to the gene trees, new genes were added to the subfamilies forming 
an extended set of subfamily collection. The sequences of extended subfamilies were then 
aligned for building HMMs and preservation calculation. Sequences from the same tree but 
not in the subfamily were used for training machine learning algorithm which will 
contribute to prediction making with site preservation. Lastly, CHO cell data was analysed 
by the models. 
 
3.1 Homolog Selection 
Homologous sequences are frequently used for function inference for newly discovered proteins. 
Homologous proteins are often grouped together by sequential similarity forming families. Both 
NCBI and Ensembl have created a collection of protein families under slightly different criteria. 
These families are built on evolutionary relations without explicit reference to functionality. 
Although members within a short genetic distance are often expected to have similar functions, it 
is not rare that members within the same family encode completely different functions. To create 
groups based upon functional similarity, PANTHER proposed subfamilies on the basis of common 
protein families. They created subfamilies based on gene duplication events since these events 
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signal functional deviation between descendant linages (Mi et al., 2005) and manual curations were 
performed to improve the quality of the subfamilies. Such classifying methods largely inspired this 
research. However, this project is focused upon mammalian genomes and at the time this thesis is 
written (2017), only seven mammalian genome were included by PANTHER collection: human, 
chimpanzee, rhesus, mouse, rat, dog and cow.  
 
Figure 3.2 Mammalian species tree generate by iTOL 3 
The figure was created using iTOL 3 (Letunic & Bork, 2016). The branch length is not 
proportional to the genetic distance. Only tree topology is presented. The tree topology 
was obtained by integrating data from Ensembl and NCBI. 
 
To allow more accurate capturing of sequence patterns we integrated more mammalian genomes 
into PANTHER subfamilies to create an extended subfamily set. The organisms involved and their 
phylogenetic relations are shown in Figure 3.2. The special phylogenetic information was retrieved 
from NCBI and Ensembl. Data from fourteen genomes were used to construct HMMs, of which three 
of them: rhesus (Macaca mulatta), rat (Rattus norvegicus) and sheep (Ovis aries) were used as a test 
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set, while others were used to train models. The selection of these organisms was based on the 
species collection of PANTHER and their annotation level. It is clear that the extended set is centred 
on mouse and human since these are model organisms with the best annotated genomes. In 
addition, according to Ensembl, Chinese hamster and CHO-K1 genome are genetically very close to 
mouse. Therefore, a training set centred on mouse could yield better performance for CHO analysis. 
 
Instead of scanning entire genomes for homologs, we use Ensembl protein families to guide 
homolog import into subfamilies. Since Ensembl protein families were built based upon sequence 
similarity, rebuilding these families using sequence searching tools such as BLAST should yield 
equivalent results. Therefore, using the existing family collection avoids the compute expensive 
recalculation. Compared to Homologene, the NCBI collection, Ensembl families cover all species 
selected for this project. By comparing Ensembl families and PANTHER subfamilies, we mapped 
subfamilies onto Ensembl families and extended the subfamilies by adding sequences in the same 
Ensembl families. For all the homologue collections we used, only members from selected 
organisms mentioned above were considered. 
 
3.2 Aligning Sequences 
All the multiple sequence aligning was performed by MAFFT 7 (version 7.313) (Katoh & Standley, 
2013). As mentioned in the previous chapter, MAFFT is one of the most accurate and fastest aligners. 
It is also frequently used by PANTHER and data management institutes such as EBI as a component 
of their pipelines. In this project, MAFFT was used to align protein family members for phylogenetic 
tree construction, subfamily members for training HMMs and query sequences to corresponding 
alignments for identifying functional important sites. To preserve the integrity of conserved patterns, 
MAFFT was set to optimise local alignment even at the cost of global alignment score at all stages. 
When aligning new sequences to a given alignment, MAFFT provides options to avoid changes in 
the given alignment and generate additional map file for location look up. A detailed description of 
MAFFT is available in section 3.8.1. It is important to note that full-length protein sequences were 
targeted in the grouping and aligning process. Therefore, proteins created by splicing are considered 
fragmented. However, compared to assessing the intactness of wildtype function in individual 
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proteins, we were more focused on the function intactness of the proteome. Therefore, as long as 
full length sequences can be recovered with certain conservation in the proteome, we considered 
the function intact.  
 
3.3 Phylogenetic Tree Construction 
PANTHER uses conciliated gene trees generated by GIGA (Thomas, 2010), a tree building tool 
highlighting gene duplication events. Gene duplication is considered an important signal of function 
deviation in PANTHER. Compared to other gene tree building methods, GIGA is more reluctant to 
achieve high likelihood derived from sequential similarity while focusing on evolutionary events. 
Therefore, it is easily confused by sequence fragments and does not guarantee high sequence 
similarity within subfamily. In fact, the early version PANTHER (7.0) did include subfamilies with 
members of such low similarity that the HMMs built on the subfamily could not recognise these 
members (these subfamilies were removed on version 8.0) (Mi et al., 2013). In addition, most 
mammalian genomes involved in this project are mainly constructed by short read assembly which 
tends to underrepresent duplication regions. Therefore, duplication events may be missed in these 
genomes, which corrupts the performance of GIGA. In this project, we first built gene trees of 
Ensembl protein families using RAxML (version 8.2.11) (Stamatakis, 2014) and TreeFix (version 1.0.2) 
(Wu et al., 2013), then added new members to PANTHER subfamilies based on the corresponding 
gene tree. Alignments of members of extended subfamilies were then used to build HMMs for 
function prediction.  
The combination of RAxML and TreeFIx was chosen since they are among the fastest and most 
accurate tree building tools (Noutahi et al., 2016b). Both tools are likelihood centred which could 
reduce the change of including distant homologs in the final subfamily collection and improve 
specificity of the HMM it derived. RAxML was first used to build preliminary unrooted binary trees 
from family member alignments generated by MAFFT. It is one of the most popular sequence-based 
gene tree constructors. Some surveys showed the RAxML outperformed other popular counterparts 
such as PHYML and MrBayes (Rasmussen & Kellis, 2011; Stamatakis et al., 2008). RAxML achieve 
accurate gene trees by maximising tree likelihood introduced by Felsenstein (1981). As mentioned 
in the previous chapter, maximising tree likelihood is highly computationally expensive. After years 
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of optimisation, the speed of RAxML has been significantly improved. RAxML provides optional 
substitutional models and is capable of automatically selecting the model that yields the highest 
likelihood. Here automatic model selection on protein families with less than 400 members was 
allowed. A GTRGamma model, which is one of the fastest models for RAxML, was assigned to protein 
families with more than 400 members. The most time expensive step for RAxML, the bootstrapping, 
was not performed at this stage. As tree modifications may be conducted at the next stage, 
examining tree confidence before the finalising step is unnecessary. The best trees generated by 
RAxML were taken for the next step. 
Gene trees generated by RAxML were then rooted using the mid-point method. Mid-point rooting 
is the simplest rooting method that requires no additional parameter. As TreeFix requires a rooted 
tree but the root will not affect performance, mid-point method was sufficient. TreeFix can reconcile 
gene trees with a given species tree without significantly lowering the likelihood of the gene tree. It 
requires a gene tree, a species tree and a map of genes and species. All trees imported should be 
rooted and binary. The binary species tree was imported from Ensembl, and only species within the 
training set were included. TreeFix adopts similar likelihood calculation as RAxML but requires a 
specified substitution model. The GTRGamma model was used again and bootstrapping was 
performed in default settings.  
 
3.4 Member Selection for Extended Subfamilies 
Gene trees generated by TreeFix were used to create new subfamily collections. At this stage only 
the topology of the gene trees was used. Ideally all members of the same subfamily should share a 
common ancestor that in turn does not have descendants from subfamilies that include members 
of different lineages (Figure 3.3 a and b). Therefore, subfamily members were first mapped onto the 
trees to locate their closest common ancestors, then proteins under the ancestors were assigned to 
the same subfamily unless the proteins were included by another subfamily entirely derived from a 
descendent node of the common ancestor (for example, Figure 3.3 b). PANTHER subfamilies were 
defined using similar criteria. However, since tools with different tree constructing criteria were 
used, the new trees may conflict with PANTHER trees. Such conflicts would result in a situation 
similar to Figure 3.3 c where sequences of the different subfamilies are highly similar. Manual 
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curation after careful review of the alignments and related annotation could be a solution for this 
situation, but this was not feasible given the lack of human curator resources available. Therefore, 
two rules were used to resolve this problem: 1) when all the involved subfamilies contain less than 
four sequences, merge these subfamilies into a bigger subfamily; and 2) only add sequences one 
topology step away from the original member into the subfamily when the first role cannot apply. 
When two subfamilies both contain a small amount of highly similar sequences, HMMs built on their 
alignment would fail to distinguish members from these subfamilies. Therefore, merging these 
subfamilies could allow clearer separation between member and non-member sequences. In rare 
cases, a subfamily contains members from multiple Ensembl protein families so that such 
subfamilies would gather members from all related families. The new collection was intended to 
extend PANTHER subfamilies instead of changing them. As these subfamilies have been released, 
used and actively maintained for a long time, major errors of the collection had been corrected by 
manual curations and experimental evidences. Changing such collection using pure in silico results 
is not likely to lead to an improvement to the collection, hence the design of the second rule. The 
tree analysis was performed using the ete3 Python package at this stage.  
After the member sequences were assigned, non-member sequences were selected as negative 
controls for final prediction. Since HMMs were allowed to report negative results, negative controls 
were used for identifying the score threshold between positive and negative result and to evaluate 
model performance. Non-member homologous sequences within the same protein family were first 
selected as negative controls. In less common cases, when non-member homologous sequences 
were not available, all non-member protein sequences from mice were used. As the mouse genome 
is well studied and relatively close to the CHO genome, being able to distinguish member sequences 
from other non-member mouse sequences indicates the model’s capacity to perform well for CHO. 
As machine learning algorithms were used at later steps, the size of negative control sets was 
designed to be similar to the positive set unless not enough negative controls were available or the 
positive set was too large. When the number of reported negative controls is close to the number 
of positive results or reaches 200, the selection process ceases. As not every negative control could 
be reported by the models, the number of reported negative control could be far less than the 
positive results or even zero, in which case thresholds were not necessary since no evidence can be 
used to support the thresholding and we want to minimise artefact bias in this process.  
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Figure 3.3 Samples showing homologs grouping with phylogenetic tree. 
Three examples of phylogenetic tree with genes are presented. Balls of different colour 
representing genes of different PANTHER subfamilies. Grouping in a and b are acceptable 
while grouping in c is not. 
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3.5 Building HMMs 
The sequences of new subfamilies were then aligned by MAFFT and HMMs were built on these 
alignments. The HMMs were built with HMMer 3 (version 3.1b1) on default settings. By default, 
HMMer evenly distributes weight to every variant observed regardless of the frequency. In addition, 
a built-in background residue pseudo-frequency would be used so that even if a residue is never 
observed in a certain position, the probability of observing that residue would not be 0. Such settings 
allow high sensitivity for detecting homologous sequences. At this stage we allowed our models to 
report non-member sequences as long as they could be distinguished from member sequences by 
scores.  
 
3.6 Preservation Calculation  
Non-synonymous SNV (nsSNV) impact on protein function has been widely studied for human 
cancer and diseases diagnosis. Therefore, most of the tools developed are biased towards humans 
and not suitable to be applied to CHO. The most popular tools that only rely upon alignment and 
phylogenetic information include SIFT (Ng & Henikoff, 2003) and PANTHER-PSEP (Tang & Thomas, 
2016). As PANTHER-PSEP reported a significantly better performance, its concepts were largely 
adopted in this project. A core concept of PANTHER-PSEP is preservation, proposed by Marini et al. 
(2010), which means site conservation within related lineage. In PANTHER-PSEP, preservation was 
reported as the molecular age for which a site remains unchanged. Conservation usually refers to 
the frequency of residues observed in position, while preservation focuses on the genetic distance 
that certain residues have gone through.  
In this project, we calculated site preservation as the number of species sharing the same variant. 
In PANTHER-PSEP preservation calculation, phylogenetic trees containing only orthologues were 
used. They constructed sequences for common ancestors and calculated preservation using those 
sequences. According to the estimation made by Ensembl, Chinese hamster and CHO shared a 
common ancestor with the mouse and the rat. Therefore, in the tree containing only species 
involved (Figure 3.4), only four ancestors (internal nodes) would be involved in the calculation. 
Although some gene trees may differ from the species tree, such incongruence should be less 
significant for orthologues from species separated by a long genetic distance. Thus, we focused on 
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three common ancestors (shown in Figure 3.4) with distinct distance, and divided species into three 
tiers accordingly so that we could calculate preservation according to the topology of the species 
tree. Molecular age was used by PANTHER-PSEP as a normalised measurement of mutation. As 
mutation rate can be affected by many factors such as population and generation time, molecular 
age is a rather approximate estimation. As we only compare preservation within subfamily, 
normalising between subfamilies was not required. Additionally, only three (out of four) distinct 
common ancestors were involved, which allows further simplifying of the preservation comparison 
into tier and species. Starting from mouse, the three tiers are referred to as tiers 1 to 3 with 
increasing genetic distance. We only calculate relative preservation. A variant shared by species only 
in tier 1 is less preserved than variants shared by species in both tier 1 and 2, and when variants are 
shared by species in the same tiers, variants shared by more species are more preserved. However, 
a variant shared by species in tier 1 and tier 3 is considered only preserved in tier 1. The maximum 
preservation that a variant can be is the number of tiers and species included by the subfamily. 
Based on these rules, the preservation of different sites of a protein can be easily compared. As the 
mouse genome is close to CHO and well annotated, preservation calculation was performed on 
mouse-related subfamilies, then transferred to CHO proteins using sequence alignment.  
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Figure 3.4 Species tree used for preservation calculation. 
Species labeled in different colour box are assigned to different tiers representing the 
variants contained by ancetor node ladeled with the same colour. As CHO is genetically 
close to mouse, in calculating position preservation, mouse was used as a starting point to 
go through the marked nodes, from botton to top, and count species that share the same 
recidue in the same position in the process. The tiers mouse went though and the number 
of species sharing the same recidue in the same position would form the preservation level. 
 
 
3.7 CHO Data Analysis and Prediction 
After the models and the preservation were obtained, Chinese hamster and CHO sequences were 
imported to be analysed. HMMer contains BLAST like tools to compare models and sequences and 
report similarity scores: the E-value and bit score. These two scores are also used by BLAST and 
should be familiar to most biologists. In simple words, E-value is the expected probability of 
observing a sequence of equal or better similarity by chance, while bit score is a form of E-value 
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normalised by the length of query sequence. We used bit scores as it only relies on similarity. We 
searched for the best matching sequences in CHO using the models. As copy number variant was 
not considered in this project, finding the best available sequence for every sequence should obtain 
the same result as searching for the best fitting models for every sequence. After the CHO scores 
were obtained, protein sequences were used to build HMMs and the negative control sequences 
were also scored. 
When negative control was available, a simple machine learning algorithm: nearest centroid 
classifier was used to identify the potentially defective or outgroup proteins. Given positive and 
negative controls, identifying such proteins can be considered as a classification problem, where 
being classified as negative means being out-of-group or potentially defective. Classification was 
done on one-dimensional data and thus a simple classification algorithm would be sufficient. 
Nearest centroid classifier is a straightforward tool for supervised classification available in Python 
package scikit-learn (Pedregosa et al., 2012). The main strategy of this classifier is gathering sample 
points that are close to each other which is consistent with our expectation of matching score 
distribution. It requires no parameters other than training data set and provides non-probabilistic 
predictions. However, it adopts an underlying assumption that the positive and negative training 
set share the same variance. The classifier was first trained by the positive and negative control sets, 
and then used to predict the classification (intact or potentially defected) of CHO proteins. The 
prediction was made according to the distance to the centroid (mean) of the training set.  
The Fowlkes-Mallows index (FWI) was used to evaluate the classification performance. FWI is an 
evaluation index based on the number of true positive (TP), false positive (FP) and false negative 
(FN) without making assumptions. It can be calculated by: 
𝐹𝑀𝐼 =
𝑇𝑃
√(𝑇𝑃 + 𝐹𝑃)(𝑇𝑃 + 𝐹𝑁)
 
FMI is bounded on 0 to 1 where 1 means perfect classification and 0 means total disagreement with 
the expectations. Only classifications with FWI higher than certain threshold would be used for 
predictions. 
CHO proteins deemed positive were then examined by preservation. To estimate mutation impact 
in function, Swiss-Prot annotations were also used with the preservation. Swiss-Prot is a subset of 
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the Uniprot Knowledgebase that has been reviewed by experts. Although Swiss-Prot covers most of 
the site annotations found, only a small proportion of sites were annotated. Preservation analysis 
could provide evidence for estimating the impact of unannotated sites. Although it is true that the 
number of mutation at highly preserved sites is not proportional to the functional impact they cause, 
high mutation rates at preserved site does suggest a higher chance of functional disruption. 
Therefore, the proportion of sites losing their preservation was used to support prediction of 
function alterations on CHO proteins. We defined function predictions as 1) defective, 2) altered or 
3) intact (also referred to as normal in places), these being 1) completely lost and no full length 
proteins found, 2) likely being altered in function to some extent, and 3) functioning as wildtype, 
respectively. The detailed parameters were decided according to a preservation survey of annotated 
sites, described in the next chapter.   
 
3.8 Related Software Description 
In this project, we used multiple publically available tools. These tools are all well developed with 
powerful functions that may not be mentioned in this thesis. Comprehensive tutorials and 
documentations of these tools are available online. For readers who are not familiar with these tools, 
we provide brief introductions on their function related to this project.  
 
3.8.1 MAFFT 
In this project, MAFFT (version 7.313) (Katoh & Standley, 2013), one of the best performing aligners, 
was used as a primary aligning tool for quickly aligning with high accuracy. MAFFT applies a 
mathematical measure known as correlation, which can achieve character-by-character comparison 
but is significantly accelerated by Fast Fourier Transform (FFT). The correlation of two sequences 
works in a swiping card manner. The head of one sequence is firstly aligned with the tail of the other 
sequence where the overlapping area is compared. Then the overlapping area is then enlarged by 
moving one sequence toward the end of the other sequence step by step, and comparisons are 
made in every step during such process. In the case of alignment protein sequences, instead of the 
actual residues, vectors, which consist of the products of the volume values and of the polarity 
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values, are used in the comparison. To align multiple sequences, a guide tree is used to progressively 
increase the number of sequences involved. When high accuracy alignments are required, the guide 
tree is reconstructed according to the alignment and is used to reconstruct the alignment again. This 
process iterates to improve aligning accuracy until the maximum iteration number is reached or no 
changes are made on the new alignment. 
MAFFT has multiple aligning algorithms built in for achieving different accuracy-speed requirements. 
In this project, the most accurate and time-consuming built-in algorithm was used for high quality 
alignments. Although applying the most time-consuming algorithm, MAFFT is still one of the fastest 
programs to achieve such quality of alignment. The actual command in this project was: 
Mafft --localpair --maxiterate 2000 --anysymbol <raw_sequence_file> > <alignment_file> 
where three options were used. Option “--anysymbol” instructs MAFFT to use not only the general 
one letter amino acid alphabet, which contains 20 usual residues but also the alphabet which 
contains unusual charters such as ‘U’ as selenocysteine. Option ‘--localpair’ instructs MAFFT to focus 
upon achieving the best performance on conserved domains and allow long gaps added in variant 
regions when aligning sequences. MAFFT provides two general alignment strategies: 1) ‘localpair’ 
focuses on aligning the most similar part of the sequence, and 2) ‘globalpair’ focuses upon achieving 
best match for every residue in the sequence, even if that means adding more short gaps in the 
alignments. Using ‘localpair’ in this project is based on the hypothesis that critical sites spread across 
the peptide as short sequence islands and regions between these islands carry more mutations. 
Adding gaps to the critical sites to achieve better matching on non-conserved regions would mislead 
the models to reduce weight on highly conserved residues. Option ‘--maxiterate 2000’ sets the 
maximum iteration number for refining alignments, avoiding excessive time cost and potential 
deadlocks. 
The same options were used when adding new sequences to a given alignment with two additional 
options ‘--addfull’ and ‘--mapout’. When ‘--addfull’ option is applied, one sequence or more will be 
required. A guide tree containing all the sequences including the new sequences, then alignment 
calculation will be performed on nodes related to new sequences. ‘--mapout’ instruct MAFFT to 
generate an additional file recording the residue position in original sequence and within the 
alignment. When ‘--mapout’ is used, an additional option ‘--keeplength’ is automatically activated 
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to avoid gaps added to the alignment and disable iterative alignment refinement so the given 
alignment will not be changed. Otherwise, gaps may be added to the given alignment even when 
alignment refinement is disabled. The command used in this project is: 
Mafft --localpair –anysymbol –addfull <new_sequence_file> --mapout <reference_alignment_file> > 
<new_alignment_file> 
When multiple cores are available, option ‘--thread’ can be used to run aligning using multiple cores, 
which could significantly increase the speed. The number of core used can be specified after the 
option. 
 
3.8.2 HMMer 
HMMer is a software first developed by Sean Eddy (1998), who further improved its searching power 
in version 3 (Eddy, 2011). HMMer (the version used is 3.1b1) is based on the Hidden Markov Model 
(HMM) which derives from Markov Chain (MC). Both types of models describe a series of events or 
states occurring in order. 
In HMMer 3, HMMs are built by a tool called hmmbuild based on the method introduced by Krogh 
et al. (1994). Three different kinds of states in alignments are modelled: match, insert and delete. 
The HMM architecture allows each site to be modelled by any of the three states. The emission 
probability of match states is subject to the observed distribution of residues on the site. Certain 
background residue distributions and pseudocounts, which essentially count residues that are not 
observed, are applied, so that the observed residues have a relative probability showing the 
significance of their observation, and other residues that are not observed have probabilities other 
than zero but subject to the background. Insertion and deletion events are modelled by insert and 
delete states respectively. The core HMM architecture used by HMMer is stringently linear, which 
complies with the linearity of biological sequences. The HMMs built to describe alignments are 
called profile HMMs (Figure 3.5 with core model in black and grey) in the literature (Eddy, 1998, 
2011; Finn et al., 2011). By default, the background residue distribution is set to the residue 
frequency in Swiss-Prot 50.8, which is hardcoded into the software. Alternatively, the background 
can be set to a uniform distribution or subject to the profile (Eddy & Wheeler, 2013). However, 
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HMMer does not simply adopt the residue frequency from the alignment but instead, weights the 
sequences in the alignment first by default. It generally assigns more weight to sequences carrying 
more variants to retain maximum information. 
 
Figure 3.5 Profile HMM with searching structure 
The figure was created by Eddy (2011). The core model is marked in black and grey. Ms 
stand for match state, Is for insertion and Ds for deletion. State S and T stand for the start 
and termination of the aligning process. State N, J, C, as N terminus, joining and C terminus, 
present the flank of core alignment. State B and E represent the beginning and ending of 
the core homologous region. Each match state is connected to an insertion state and a 
deletion state which could result in skipping in any number of match states. 
One of the most crucial applications of HMMs is to search for matching sequences in a database or, 
conversely, matching a query sequence with one of the models in the HMM database. Hmmsearch 
and hmmscan are the tools designed for such purposes in the HMMer toolbox. To achieve database 
searching a searching engine is required. Essentially, matching model and sequence is to calculate 
their similarity. For HMMs, forward algorithm and Viterbi algorithm are two fundamental methods 
that can achieve such purpose. Forward algorithm is used to calculate the probability of achieving a 
certain hidden state given the observed sequence, while the Viterbi algorithm is used to calculate 
the most likely sequence of hidden state given the sequence of an observed state. Therefore, every 
possible hidden state in the same step would be considered when calculating the next step in the 
forward algorithm but only the optimum of these states is calculated in Viterbi. As a result, the 
Viterbi algorithm is less computationally expensive as the heuristic strategy is applied. In HMMer, 
searching with Viterbi algorithm is 3- to 9-fold faster than forward algorithm so that it is more 
preferable (Eddy, 2011) 
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Figure 3.6 HMMer 3 HMM for comparing sequences 
The figure was acquired from Eddy (2011). State S and T stand for the start and termination 
of the aligning process. State N, J and C are flank states standing for N terminus, joining and 
C terminus. State B and E stand for the beginning and end of homologous region. State M 
in the core process stands for matches in the alignment. Compared to the structure shown 
in Figure 3.5, deletion states and insertion states are removed forming ungapped alignment 
segments.  
Whether implementing the forward or Viterbi algorithm in searching, the goal is to calculate the 
likelihood of the hidden sequence given the query sequence as observed. However, searching using 
ordinary methods are far more slower than BLAST, which makes it inappropriate to apply to 
database searching (Eddy, 2011). To extend the application of HMM, Eddy group developed a fast 
model-based searching method to allow searching with HMM to reach a comparable speed with 
BLAST. Another model is built on part of the HMM to guide the searching (Figure 3.6). In this model, 
the insertion and deletion states in the profile HMM are not considered, and only the match states 
are considered, which means it is the matched sequences without gaps that the program is 
searching for. The matching starts at state B, which can then transit to any match state. The model 
allows the matching to start at any point of the model and correspondingly any point of the query 
sequence. After the first match is found, the following sequence is then automatically compared to 
the following matching state until the similarity score of the match drops below a certain point, 
which is decided by the transition probabilities from state E to state J and C. Certain thresholds can 
be set so that short matched sequences that do not score highly enough are excluded. Generally, 
long matched sequences with high matching scores can continue with a few low score matches, 
which makes searching less sensitive towards discrete point mutations. As only a part of the HMM 
is involved in searching and it is effectively simplified, the computational power requirement is 
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highly reduced. Parallel versions of the method are also available for quick database searching with 
high performance computers. 
Similar to BLAST, HMMer reports the matched sequences along with two statistical scores, the E-
value and the bit score. The E-value, as mentioned previously, is the expected possibility of having 
a sequence with equal or better similarity by chance. It can be calculated as: 
𝐸 = 𝐾𝑚𝑛𝑒−𝜆𝑆 
where n, m are the length of query sequence and of the sequences in the database, which also 
define the searching space, while K and λ are the scales of the size of the searching space and 
scoring system of the segments, and S is the similarity score set in the algorithm for discarding 
fragments with similarity below the score (Madden, 2013). The E-value relates to the length of the 
query sequence which is reflected by n, the size of the database which is reflected by m and the 
similarity score S which is affected by many factors of the scoring system. The lower the E-value, the 
less likely that the match occurs by chance, which equally means the more significant the match is 
statistically. 
Compared to the E-value, bit scores only relate to the similarity score and the scoring system but 
not the length of the query and the size of the database. This is given by the formula: 
𝑆′ =
𝜆𝑆 − ln𝐾
ln 2
 
the bit score S’ can be considered a normalised version of S, which is the raw score generated 
directly by the scoring system as K and λ are derived from the scoring system. Such normalisation 
allows bit scores from different alignment to be compared.  
 
3.8.3 RAxML 
Randomised axelerated maximum likelihood (RAxML) (the version used in this project is 8.2.11) is 
one of the most widely used sequence-based phylogenetic tree building software. Like a lot of other 
tools, RAxML builds phylogenetic trees by maximising likelihood proposed by Felsenstein (1981). In 
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general, such likelihood is the product of prior probability derived from residue or base distribution, 
the probability of change of branches and the length of the branches. The computational complicity 
increases with the number of branches, therefore, calculating likelihood for trees involving 10,000 
taxa would be time consuming. To maximise the likelihood of a tree, tree rearrangement would be 
conducted many times searching the potential solutions. As it is impossible to test all possible 
topology for trees of usual size, parsimony methods are used. A general strategy is that first 
generating a tree with simple algorithms which often do not encounter likelihood calculation, then 
rearranging a small part of the tree to reach local maximum in likelihood with hill climbing methods 
and then repeating the maximising process on other parts without changing the maximised 
branches. Random rearranging is used for generating proposals in hill climbing for maximum 
likelihood. In this way, since only a few branches are rearranged every step, likelihood calculation 
can be largely simplified as only the likelihood of changed branches need recalculation. To enable 
multi-thread computing on high performance computers (HPCs), specialised versions of RAxML are 
made available. The actual distribution used in this project is RAxML-PTHREADS-SSE3, a multi-thread 
vectorised computing version. 
When calculating probability for change for likelihood, certain substitution models are required to 
obtain the substitution rate. In RAxML, multiple models are available, of which the GTRCAT is the 
fastest for large tree calculation. However, according to the manual provided by the developers, 
GTRCAT is not recommended when taxa is less than 50 and GTRGamma should be used in this case. 
GTRGamma is a general time reversible model based on Gamma distribution mutation rate. 
Automatic model selection is also available. In this case, the program selects the model which yields 
the highest likelihood. However, as tree topology is much more important than branch length in this 
project, a slight change in likelihood caused be model selection is acceptable. 
After tree with maximum likelihood is acquired, bootstrapping can be used to evaluate how well the 
data supports the result. In this process, pseudo-sequences are created according to the input 
alignment and added to the sequence poll which will be resampled to generate a new sequence 
collection. Such collection will then be used to build the tree with maximum likelihood using the 
protocol described above. The resampling process will be repeated many times and the more the 
same tree is acquired, the better the tree is supported by the data. However, this bootstrapping is 
highly computationally expensive, although it has been significantly accelerated in RAxML.  
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3.8.4 TreeFix 
TreeFix (used version 1.0.2) is one of the best reconciliation tools. Two series of TreeFix, TreeFix and 
TreeFix-DTL, are available for eukaryotic and prokaryotic genomes respectively. It requires a rooted 
species tree, a map of gene and species, a preliminary gene tree (preferably the ML tree) and the 
corresponding alignment as input to generate a reconciled gene tree. TreeFix reconcile species trees 
and gene trees by minimising reconciliation cost within the tree topology space where the likelihood 
is statistically equivalent. It assumes that minimum reconciliation cost can be reached in that tree 
space, but when the assumption is not applicable, ML trees with high reconciliation cost will be 
returned. 
TreeFix calculates likelihood using RAxML package. It is recommended that the same substitution 
model should be used for both building ML trees as input and the reconciliation process. The model 
selected in this project is GTRGamma. To estimate the significance between different tree 
topologies, TreeFix conducts statistical tests on likelihood change between these trees, with the null 
hypothesis being all trees are equally supported by the alignments. TreeFix calculates reconciliation 
cost as the minimum evolutionary events, loss and duplications, required to solve the incongruence 
between the species tree and the gene tree. 
Bootstrapping analysis is also available on TreeFix. However, TreeFix only resample gene trees with 
same topology as the input tree and corrected branch length as bootstrapping from ML gene tree 
construction would be too computationally expensive.   
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4 Model validation and performance 
 
In this chapter, details of validations of HMMs and preservation calculations are described. After 
examining model performance, criteria and standards decided by the behaviours or performance 
of the models will be described and justified.  
During the model construction process, 16,749 Ensembl protein families were involved, of which 
15,620 had phylogenetic trees built, while the rest of the families contained fewer than three 
members from the selected genomes. These protein families derived 19,408 subfamilies where 342 
original subfamilies were merged into others subfamilies in the final set. Equal number of HMMs 
were built on these subfamilies. Site preservation was calculated on these subfamilies, however, 
only 18,594 of them had at least one member annotated by Swiss-Prot. The performance of the 
HMMs was evaluated using gene sets from rat, rhesus and sheep, while the performance of 
preservation was investigated using PANTHER-PSEP results and Swiss-Prot site annotation.  
 
4.1 HMM validation 
The HMMs built in this project were used for two purposes: identifying the subfamilies to which 
query sequences belong, and identifying sequences with large area mutations including protein 
fragments. Amid these two purposes, the former can only be achieved by HMMs while the latter 
was aided by preservation calculated in other steps. Therefore, it is more important that the HMMs 
can correctly assign sequences to the subfamilies, while larger error on predicting protein defects 
is acceptable. 
Subfamily collections of rat and rhesus were used to validate model performance on assigning 
sequences. These two genomes are included by the original PANTHER subfamilies but were not 
used for training the HMMs. Models built on subfamilies with no members from the corresponding 
genome were not involved in the validation as they will always assign proteins to subfamilies 
different from PANTHER. The rest of the models were used to find the best matched proteins on 
these genomes. Recovering members in this process would mean being successful in assigning the 
correct subfamilies. As a result, 16,258 of 17,634 models successfully recovered their member in 
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rat making up a correct rate of 92.2%. The numbers for rhesus were 15,385, 16,694 and 92.2%. We 
speculated that the main error came from subfamilies of the same families which are inherently 
highly similar. Therefore, we further investigated model accuracy on assigning proteins to correct 
families. The number of models correctly assigning families was 17,634 in rat and 16,385 for rhesus, 
making up 98.7% and 98.1% respectively. These numbers confirmed our speculation. Based upon 
these numbers and the numbers for subfamily assigning, we believe that our models are able to 
assign proteins to correct homologue groups. 
In the prediction process, homologous sequences not included by the subfamily were used as 
negative controls. However, not all subfamilies have homologous sequences available from the 
selected genomes and 1,126 subfamilies fell into this situation. For these subfamilies, predictions 
were made solely based on site preservation. The predictions made by models would be largely 
affected by the scores of corresponding negative controls. To investigate the difference between 
scores of positive and negative controls, a t-test was performed on these two sets of scores for 
every subfamily with negative controls. In the 18,282 models with negative controls, 1,186 were 
not applicable for t-test since only one negative control yield a score; 1,836 have a two-tail P-value 
larger than 0.05 and the number increases to 2,531 for a P-value of 0.01. Therefore, we believe 
15,260 (83.5%) models should provide good predictions at a significance level of 0.05. However, we 
brought all models to the next validating step. For the models without negative controls, positive 
predictions would be reported and passed to the next step. 
In the validation of predicting protein intactness, a procedure similar to subfamily assigning 
validation was applied. Models of subfamilies not having members from the related genome were 
firstly removed and then the best matching sequences were used for validation. However, in this 
case, we used not only proteins from rat and rhesus, but also proteins from sheep which is not 
included by PANTHER subfamilies. Therefore, all models were used for sheep proteins. We 
expected most of the proteins to return positive results. Eventually, the models returned 1,682 
(9.6%) negative predictions out of 17,606 reported predictions for rat proteins and the number for 
rhesus were 1,630 (9.8%) and 16,706. For sheep proteins, which have not been included by 
PANTHER, from the 19,373 reported models 2,673 (13.8%) of them reported negative results. To 
investigate the cause of significant higher negative rate on sheep proteins, we examined prediction 
results on rat and rhesus proteins using all models. It showed dramatic increase on both rat and 
rhesus, being 15.5% (2,989 out of 19,312) and 19.5% (3,759 out of 19,309) respectively. This result 
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showed that most of the models of subfamilies not involving the species yielded negative 
predictions. 1,307 negative predictions for rat came from 1,706 unrelated subfamilies and the 
numbers for rhesus were 2,129 from 2,603 subfamilies. As homologous sequences not in the 
subfamily were used as negative controls, when homologous sequences are identified by models 
of subfamilies of the same protein family, negative predictions will be made. Therefore, high 
negative rate caused by unrelated subfamilies can be considered as evidence showing that models 
work as expected. On the other hand, when unrelated subfamilies were removed, a significant 
proportion (about 10%) of proteins were predicted defected. It is highly likely that protein 
fragments are stored as a protein in these data set and they should be diagnosed as defected, but 
we were expecting a lower proportion. Since we used models to find the best matching sequences, 
only protein fragments not having whole protein homologs should be reported as defected. 
Therefore, we were only expecting a small percentage of negative prediction.  
To address the cause of unexpectedly high rate of negative prediction, we further investigated the 
performance of classification by nearest centroid in the predicting process. Along with the 
predictions, the FMI was reported suggesting the quality of the predictions. A FMI close to 1 means 
perfect classification on training set while a FMI close to 0 stands for the opposite. One of the main 
causes of low FMI is indistinct separation of scores of positive and negative control. Therefore, the 
list of models with P-value higher than 0.05 in t-test was compared with the list of models with a 
FMI lower than 0.7. The FMI threshold of 0.7 was selected since it is the FMI obtained when all the 
samples are considered intact or defect and the number of positive and negative controls are equal. 
This comparison showed that 1,548 out of 1,836 models that failed t-test at a level of 0.05 have a 
FMI lower than 0.7. In total, there are 6,144 models with FMI lower than 0.7 reported on prediction 
for sheep proteins, accounting for 31.7% of the total models reported. After removing models with 
low FMI, only 515 models and 592 models, accounting for 2.9% and 3.5% of models of related 
subfamilies, reported negative for rat and rhesus proteins respectively. For sheep proteins which 
examined by all models, 909 (4.7%) models reported negative. It is important to note that when a 
model returns negative prediction, it does not necessarily mean the protein identified by this model 
is defected, although it could be the case. Instead, it actually means the protein carrying the 
function represented by the subfamily is defected in the corresponding species. The protein 
identified by the model could be identified by another model which reports a positive result and 
the subfamily whose model returns a negative result may not be needed by the species. Therefore, 
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for rat and rhesus, as only related subfamilies were accounted, negative predictions means the 
proteomes only contain fragmented proteins, probably caused by splicing effects but this could also 
be the result of incorrect gene or coding region boundary, or bad models caused by incorrect 
alignment or improper homolog collection. The negative results also means unrelated subfamilies 
for sheep proteins and also for CHO proteins in later sections. The prediction from models with low 
FMI were carried on to preservation analysis. Since the main function of HMMs is assigning 
subfamilies, the intactness prediction works as a filter at this stage. Therefore, only confident 
negative predictions would be cut off when CHO proteins were examined. 
 
4.2 Preservation analysis 
The preservation model is built for identifying functionally important sites. It can complement HMM 
predictions with local conservation information to generate more accurate results. Although 
summarising site preservation on whole sequence could achieve functional estimation like HMMs, 
in this project, site preservation was centred on the functional effect of single site. As the 
preservation analysis in this project is largely motivated by PANTHER-PSEP, we compare our 
preservation level with the molecular age calculated by PANTHER-PSEP for validation. Then we 
investigated preservation distribution on annotated sites whose information was obtained from 
Swiss-prot. The preservation effect on prediction was also discussed in this section. 
In order to compare molecular age with our preservation level, the precomputed molecular age 
results were retrieved from PANTHER ftp site. PANTHER-PSEP automatically recognises the 
member most similar to the query sequence within its database and starts calculating molecular 
age from that member. However, in this stage, our approach requires a specified starting species 
from the selected species collection. Human was selected for this validation process since 
PANTHER-PSEP was built for recognising disease-causing site variant and human proteins are most 
well-annotated. However, when CHO proteins were applied to the model, mouse proteins were 
used as the starting point for preservation calculation. Our preservation level was presented with 
a tier number and a species number and the preservation increases with firstly tier number then 
with species number. The average molecular age of sites with same preservation level was used for 
the comparison. The result is shown in Figure 4.1. Note that since there was only one site preserved 
on two tiers with nine species, it was not shown in the Figure 4.1 due to lack of statistical 
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significance. The Figure 4.1 shows a trend of increase of molecular age with preservation level. 
However, for the levels of the beginning (especially first two levels) of every tiers, the molecular 
age increases unexpectedly. This could be the result of gene trees that are significantly different 
from the species tree or a more distant homolog not included by the selected species in this project. 
PANTHER includes much more species than that in this project, resulting in much longer linages. 
PANTHER-PSEP use reconstruction probability to build links between distant homologs, which 
means even when a variant is not observed in all internal notes, as long as it is observed at both 
ends of the linage it could be considered as preserved throughout the entire linage. Apart from 
these, the molecular age seems to correlate well with our preservation levels, though not linear. 
When we inspect the PANTHER-PSEP results, we found that although molecular age is used, the 
outcome ages are highly discrete and could actually be fitted in a level system. Overall, only 22 
different ages are assigned to sites of human proteins (supplement 1). Therefore, although we used 
a different calculating protocol, the level system we used performs more similar to the molecular 
age from PANTHER-PSEP than we expected. 
 
 
Figure 4.1 Average of molecular age on preservation levels. 
The molecular age is shown in the Y axis while the preservation level is shown in the X axis. 
The average molecular age for sites of the preservation level is presented. A trend of 
increase of molecular age with preservation level is presented, showing correlation 
between two metrics. However, for the levels of the beginning (especially first two levels) 
of every tiers, the molecular age increases unexpectedly. 
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Table 4.1 The numbers of sites with different marks with different preservation level. 
The sum of sites annotated by different market are shown at the bottom with the two-tail 
p-values calculated in t-test with the numbers in the second column as reference. The p-
values are all smaller than 0.01, showing significant difference in distribution against the 
general distribution.    
Preserv
ation 
total act_site 
np_bin
d 
ca_bind binding metal zn_fing 
dna_bi
nd 
mutage
n 
variant 
1.1 256520 11 328 210 19 31 10886 1330 187 2905 
1.2 464289 42 558 74 93 96 36381 524 214 2531 
1.3 196628 4 120 44 31 19 7097 299 95 1015 
1.4 317858 10 167 56 17 14 12569 417 242 2041 
2.3 84169 0 35 19 7 3 848 115 69 660 
2.4 107730 2 34 68 3 2 892 200 95 398 
2.5 165218 5 62 29 18 9 1330 503 142 797 
2.6 126027 11 80 43 12 20 1538 103 115 760 
2.7 81565 7 63 45 13 10 1201 85 69 416 
2.8 34622 3 68 8 15 4 186 24 29 210 
3.4 110580 13 209 53 21 39 917 211 127 565 
3.5 345252 22 507 95 47 78 3149 1341 275 2751 
3.6 830599 14 705 346 38 49 6215 2242 507 1933 
3.7 149938
0 
69 1349 304 131 136 13580 3440 1343 4354 
3.8 231268
2 
195 2641 691 405 352 20404 4285 2340 7635 
3.9 308951
7 
521 5796 1415 913 1088 30690 10786 4412 16069 
3.10 213803
1 
746 7192 1040 1536 1464 31297 10502 5555 22982 
3.11 306 0 0 0 0 0 0 0 0 0 
sum 121609
73 
1675 19914 4540 3319 3414 179180 36407 15816 68022 
t-test 
pvalue 
 
0.4182
% 
0.4232
% 
0.419% 0.4186
% 
0.4187
% 
0.4703
% 
0.4279
% 
0.4221
% 
0.4369
% 
 
 
The preservation results were then aligned with Swiss-prot site annotations. As we wanted to 
investigate the preservation of functionally important sites, function related annotations were 
mainly involved. Sites annotated with marks of ‘ACT_SITE’, ‘NP_BIND’, ‘CA_BIND’, ‘BINDING’, 
‘METAL’ AND ‘ZN_FING’ were selected as focus groups, of which ‘ACT_SITE’ and ‘NP_BIND’ standing 
for active sites and nucleotide, such as ATP and cAMP, binding sites respectively, were excepted to 
be most conserved. Apart from these function related sites, sites annotated with marks of 
‘MUTAGEN’ and ‘VARIANT’ were also used as they were considered less conserved. Distribution of 
overall site preservation was used as base-line to highlight change in preservation. The numbers of 
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sites with different marks with different preservation level are shown in Table 4.1. The p-values of 
two-tails t-test against overall preservation level distribution was shown in the last raw, all showing 
significant difference from the base-line distribution.  
 
Further proportional distribution comparison with the base-line distribution is shown in Figure 4.2, 
active sites and nucleotide binding sites are mostly of high level of preservation which is consistent 
with our expectation. Surprisingly, general binding sites and metal binding sites also expressed high 
preservation throughout different species. Note that in Swiss-prot annotation, general binding sites 
stand for protein binding with ligands, substrates, products and cofactors. Although when binding 
with metal particles, related sites will be annotated as metal binding, some of these sites are also 
annotated as general binding sites. Therefore, as different species may react very differently to the 
same substances, especially when the immune system is involved, we expected general binding to 
be less preserved than some specific bindings such as calcium binding (marked ‘CA_BIND’) and 
nucleotide binding. However, the results show that the general binding sites show more 
preservation than the calcium and nucleotide binds. On the other hand, zin finger regions show the 
highest specificity where most of them are not shared by distant species. Mutagen and variant stand 
for site variants created on branch and detected in nature respectively. They are mostly disease 
related but we noticed some of these sites were further annotated as neutral. Therefore, we 
expected them to be close to the general distribution. However, they show significant bias of high 
preservation. Since these two marks contain various sites with or without functional effects, the 
cause of high preservation remains unknown.   
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Figure 4.2 Preservation distributions on different annotated sites. 
Preservation levels are marked at the X axis and percentage of total number of sites related 
to the annotation marker is shown on the Y axis. The annotated sites shown in all the graphs 
are a: active sites, b: nucleotide phosphate binding sites, c: general binding regions, d: 
metal binding sites, e: DNA binding regions, f: Calcium binding sites, g: zing fingers and h: 
sites had been artificially mutated in experiments. All types of annotated sites presented a 
preservation level above the general preservation profile except the region related to zing 
fingers. 
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The preservation distribution above also indicated that the increase of preservation often 
presents as increase of number of sites with the highest preservation level (ie 3.9 and 3.10). 
Therefore, we further used the proportion of these sites, referred as sequential preservation 
in later sections, for function intactness prediction in sequence level. The proportion of sites 
with these preservation levels were first calculated from alignments with human or mouse as 
the last note of the linage. There was a significant proportion of subfamilies not containing 
any site of such high preservation level. The number of these subfamily were 6,453 calculated 
from human and 6,512 from mouse. This was mainly caused by the definition of these 
subfamilies. One of the drawbacks of using only high preservation sites is that it can only be 
applied to subfamilies with long history. However, there were also subfamilies containing only 
sites with high preservation. Then the rat proteins and rhesus proteins were added to these 
alignments in order to count the number of high preservation sites that remain preserved in 
these two species (supplement 2 and 3). In this process, they used the preservation calculated 
from close related species, which was mouse for rat and human for rhesus. Excluding 
subfamilies without site of high preservation, 385 subfamilies detected mutations in over 50% 
of these sites in rat proteins and the number for rhesus is 649. After overlapping with the 
negative predictions generated by HMMs, the number became 204 and 197 respectively. 
Note that within these overlapping results, a big portion of subfamilies (144 for rat and 124 
for rhesus) were overlapped by negative results with FMIs higher than 0.7. The details of 
preservation and alignment of these results can be found on supplement 2 and 3. Relatively 
loss alignment confirmed these predictions. Therefore, we considered the function to be 
defected when the related subfamily reported negative results agreed by both high 
preservation sites and high quality HMMs. Also when the subfamily HMM failed to find 
matches, the function it carries would be considered defected. As high preservation sites 
provide more confident results with lower coverage, we extended the coverage by using sites 
with the two highest preservation levels from among the subfamily instead of the highest of 
all training data. This allows automatic adjustment of local high preservation standard while 
recovering the same results for subfamilies reported by using only preservation level 3.9 and 
3.10. However, to maintain prediction confidence, only sites with preservation in at least 4 
species across all 3 tiers would be considered as sites with high preservation. Functions 
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related to subfamilies reporting negative predictions by HMM or mutations on more than 25% 
of sites with high preservation of local standard were considered altered. These criteria for 
predicting defected and altered functions with subfamilies were applied to rat and rhesus 
protein with and without unrelated subfamilies. The result is shown in the Table 4.2. A 
substantial portion of subfamilies returned altered results with or without unrelated 
subfamilies indicating the models are very sensitive toward species-specific features and 
unrelated subfamilies are highly likely to return altered or defected predictions. 
 
Table 4.2 Functional prediction results for rat and rhesus. 
Number of subfamily with non-conserved predictions are shown in the table. The 
following numbers are the results obtained after subfamilies not related to the 
species were removed. Significant dropping of number after the removal suggested 
irrelevant subfamily to be one of the main sources of negative predictions. 
subfamily Rat  Rhesus 
Defected 203 327 
Altered 3105 4249 
Defected(filtered) 142 121 
Altered(filtered) 1911 2357 
 
 
Apart from making prediction for defected or altered functions, preservation can be used to 
compare conservation between homologs or function pathways. For example, as mentioned 
above, some subfamilies contain only high preservation sites but not all these subfamilies 
yield the same results when the preservation was calculated from different species. High 
preservation means the same variant is shared by most, if not all, the species selected as 
training set in this project. Therefore, most of the results were identical regardless of the 
starting species. Thus, different high preservation site number in a highly conserved subfamily 
mean the starting species expressed species-specific features in some sites of the conserved 
protein. For example, a subfamily (PTHR11639:SF90) (supplement 1) containing regulation 
protein S100A10. Although the regulation function of this subfamily remains unclear, it had 
been found to be highly conserved within mammals. However, the mouse homolog of this 
subfamily contain eight sites (14th, 18th, 24th, 25th, 37th, 73th, 76th and 90th) different from at 
least 9 (out of 10) other mammals involved in the training process. Most of these sites have 
not been annotated except the 37th residue which would go through PTM process and form 
covalent linkage with another protein SUMO2. Another example would be another subfamily 
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(PTHR21141SF55) of 60S acidic ribosomal proteins. The mouse homolog in this subfamily 
contains three variant sites compared to other homologs but none of them have been 
annotated yet. Sites of such kinds could be the result of genetic draft without any functional 
effects but also could be the genetic signature of the species. Interesting species features may 
be found on highly conserved proteins and these proteins are mostly related to core biological 
processes that could affect many downstream processes. However, being highly conserved in 
evolution means most modifications introduced by random mutations had been wiped out 
by natural selection due to the significant negative effects they caused. The current cell 
engineering strategies tend to minimise unnecessary effects on cell biology. Since these 
proteins are more likely to affect multiple processes, they are rarely the engineering target. 
However, since radical changes had been induced to CHO in the process of immortalisation 
and adaptation of different environments, mutations rejected by previous evolution might 
now be beneficial. Comparing CHO homologs of these proteins with our models could suggest 
potential advantageous mutations which are the engineering target. 
After sequential preservation was obtained, we mapped the subfamilies along with their 
preservation onto GO using enrichment analysis tool available on PANTHER website. The 
sequential preservation was calculated from human. The PANTHER GO-slim of biological 
process is used and only results with a p-value lower than 0.05 were reported. The result table 
(Table 4.3) is presented in hierarchical order derived from GO structure. It shows significant 
positive enrichments on core processes, especially metabolic processes, shared by many 
species. While also negative enrichments on processes with species specificity such as 
response to stimulus, immune response and regulation is presented, which confirm our 
preservation calculation in processes levels.  
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Table 4.3 Part of result of enrichment analysis from PANTHER website. 
The GO terms are presented in hierarchical order and the most distinct terms (lowest 
P-value) are shown in this table. 
PANTHER GO-Slim Biological Process No. of 
subfamily 
Enrichmen
t (+/-) 
P value 
sensory perception of chemical stimulus (GO:0007606) 70 -  0.00E00 
  sensory perception (GO:0007600) 80 -  3.02E-14 
    neurological system process (GO:0050877) 111 -  1.04E-11 
      system process (GO:0003008) 115 -  2.22E-11 
        single-multicellular organism process 
(GO:0044707) 
146 -  7.16E-09 
          multicellular organismal process (GO:0032501) 147 -  6.65E-09 
cell surface receptor signaling pathway (GO:0007166)  125 -  4.98E-13 
  signal transduction (GO:0007165) 215 -  1.38E-06 
    cell communication (GO:0007154) 248 -  3.69E-05 
response to stimulus (GO:0050896)  294 -  1.31E-10 
metabolic process (GO:0008152) 649 +  1.78E-04 
  nucleobase-containing compound metabolic process 
(GO:0006139) 
230 +  2.49E-03 
    primary metabolic process (GO:0044238) 530 +  6.92E-05 
immune response (GO:0006955) 27 -  5.18E-07 
cell adhesion (GO:0007155) 25 -  3.59E-02 
  biological adhesion (GO:0022610) 25 -  3.59E-02 
cellular amino acid metabolic process (GO:0006520)  65 +  1.87E-04 
regulation of biological process (GO:0050789)  347 -  2.36E-09 
  biological regulation (GO:0065007) 385 -  1.33E-07 
lipid metabolic process (GO:0006629)  98 +  1.22E-02 
phosphate-containing compound metabolic process 
(GO:0006796)  
117 +  1.07E-04 
 
 
 
4.3 Summary 
The HMM and preservation models were verified using well sequenced and annotated 
genomes. The HMM models demonstrated high accuracy in assigning query proteins to 
subfamilies but comparatively lower confidence in predicting intactness. The preservation 
64 
 
models generate similar result with PANTHER-PSEP. By examining the preservation level of 
critical function sites, we addressed the preservation levels highly correlated to these sites 
and used them to calculate sequential preservation which was then used to assist predictions. 
However, both HMM and preservation suffer restriction of conservation where both their 
accuracy and coverage reduce alone with conservation. Although the sequential preservation 
could only be applied to the relatively conserved subfamilies, it could capture species-specific 
features ranging from intra-sequence level to cellular function level. 
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5 Model Predictions on CHO Related Data 
In this project, we involved all three CHO related genomes available online: a CHO-K1 genome, 
CHO-K1GS genome and a Chinese hamster genomes. An overview of the prediction is first 
presented reporting the number of different predictions in different genomes. Then 100 
subfamilies reported homologs with normal function in CHO-K1 and 100 subfamilies reported 
defected CHO-K1 homologs were verified with BLAST. In the verification process, we blast 
mouse homologs used to train the model against the CHO-K1 genome for the best reciprocal 
hits.  
5.1 Prediction Overview 
Although the three CHO related genomes were annotated by different pipelines (CHO-K1 and 
Chinese hamster annotated by NCBI RefSeq and CHO-K1GS by Horizon Eagle), they were 
referred by each other during the annotating process. We first conducted analysis on 
subfamilies using models to identify best matching protein sequences. By applying the 
protocols and criteria described in the previous chapters, we identified a significant portion 
of altered function in proteins from all three genomes (Table 5.1). Only numbers are discussed 
at this point and more details of these proteins regarding their functions and biological effects 
will be discussed later in this chapter (on session 5.4). The number of subfamilies failed to find 
significant matches are also reported in the table. Unexpectedly, the latest CHO-K1GS 
proteins yield least defected or altered results, although more subfamilies reported altered 
or defected prediction in CHO-K1 than Chinese hamster as expected. This could be caused by 
the quality control of annotating pipeline which could remove sequences less similar to 
known sequences keeping only the comparatively conserved sequences. Note that on the 
Ensembl website, another annotation generated by Ensembl on Chinese hamster genome 
(probably CHO-K1 genome as they used the CriGri_1.0 assembly with was first published with 
the CHO-K1 genome) other than CHO-K1GS is published, containing only 19,617 coding genes 
which is significantly different from the RefSeq annotation containing 27,752 genes. The 
newer Ensembl annotation was not used in this project as the RefSeq annotation was applied. 
Such inconsistency between the annotations is likely to be the result of insufficient re-
sequencing data for CHO. Therefore, significant improvements could be made on annotation 
when more data is available. 
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Table 5.1 Number of subfamily returned negative result on CHO related genomes. 
Subfamily CHO-K1 CHO-K1GS Chinese Hamster 
Defect 142 66 160 
Alter  3695 2985 3374 
No match 59 68 96 
Total 3896 3119 3630 
 
According to the validation on rat and rhesus proteins, unrelated subfamilies could contribute 
to a significant part of the altered and defected predictions. Therefore, we attempted to 
identify the unrelated subfamilies by using protein sequences to find the best matching 
subfamilies. Subfamilies whose best matching proteins matched better to another subfamily 
would be considered unrelated. An overview result of identifying best matching subfamilies 
is shown in Table 5.2. Accordingly, proteins matched with subfamilies returned altered or 
defected in the result above were deemed altered or defected correspondingly. Clearly, all 
the altered and defected proteins were converged to a smaller number of subfamilies. It is 
important to note that the predicted defect or altered proteins are not necessarily defected 
or altered since, they may belong to subfamilies not covered by this project. The validation 
result showed our subfamily set should be covering about 17,000 related subfamily for rodent 
and primate species. Given a total gene number projection of 24,000 to 30,000 for these 
species, the subfamily coverage could be arguably low. However, given both the subfamily 
model and the protein recognising each other as best match and the subfamily model 
reporting negative prediction, there should be a good chance that the protein is significantly 
damaged by the mutations.  
 
Table 5.2 Functional prediction of proteins on CHO related genomes. 
Numbers of protein with different prediction are shown followed by the number of 
subfamilies which the proteins with negative prediction belong to. 
 CHO-K1 CHO-K1GS Chinese Hamster 
Defect protein 121 49 65 
Altered protein 4361 2926 3786 
Intact protein 26788 24975 25566 
Subfamilies with 
defect protein 
81 41 35 
Subfamilies with 
altered protein 
2404 1682 2119 
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5.2 Verification with BLAST 
 
To further examine the quality of predictions generated by our models, we verified some of 
our results with BLAST. Clearly, our models perform differently compared to BLAST in many 
aspects such as scoring method, aligning algorithm and sensitivity. However, the main 
difference should not affect their agreement on extreme samples, which are either highly 
conserved homologs or completely different sequence pairs. Therefore, we randomly 
selected (using random number generated by the computer) 100 subfamilies reported intact 
and 100 subfamilies reported defected for this verification. These predictions were made by 
using subfamily models to find the best matches on CHO proteins. Thus, we selected a 
member of the subfamily to BLAST against all CHO proteins to obtain the best hit on CHO. 
Since mouse is genetically close to CHO and well annotated as a model organism, mouse 
homologs in the selected subfamilies were used to BLAST against the proteins derided from 
the CHO-K1 genome. We considered the percentage of identical site and the percentage of 
matching region the significant metrics on comparing the BLAST result of two sets of 
sequences (supplement 4 and 5). Default settings of blastp was used for this verification. As 
expected, the sequences of intact prediction significantly exceeded those of other groups on 
both percentage of identical site and matching region. On average, the intact group achieved 
an identical percentage of 89% while covering 92% of the best matching CHO protein. On the 
other hand, the number of defect group were 59% and 55%.  
The difference between scores generated by BLAST and our models were compared in detail 
in Figure 5.1 and Figure 5.2. In these graphs, samples were plotted by their score generated 
by both BLAST and the preservation models. Although our method includes HMM models and 
preservation models, sequential preservation was used to represent scores generated by our 
models since the thresholds for HMM scores were determined accordingly by machine 
learning algorithms, while threshold for preservation score was set at 0.75. Meanwhile, the 
similarity score generated by BLAST can also be presented by two parameters: identity and 
coverage. Both of these parameters are scaled between 0 and 1. Low score on either 
parameter would lead to negative predictions from our models. Therefore, the lower value 
of the two parameter was used to represent BLAST similarity in the comparison.   
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Figure 5.1 shows the comparison on predicted intact proteins. 0.75 was used as a threshold 
for sequential preservation so that all proteins in the intact group have preservation scores 
higher than 0.75. In most cases, BLAST generated high scores agreeing with our models. 
However, if a same threshold of 0.75 was applied to predict intact proteins, 7 out of the 100 
randomly selected samples would be predicted altered or defected. On the other hand, Figure 
5.2 shows the scores of samples of predicted defeated proteins. If the sample threshold was 
applied on BLAST scores, 25 of them would be predicted differently. These samples showed 
BLAST agrees 93% of the positive prediction and 75% of the negative predictions making up 
an overall agreement of 84%. 
 
 
Figure 5.1 Comparison of BLAST similarity and preservation score of predicted 
intact proteins. 
The lowest blast similarity is set to be the lower value of identity and coverage 
generated by BLAST. Most samples are concentrated on the top right corner showing 
that the two methods agree with each other in most cases. 
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Figure 5.2 Comparison of BLAST similarity and preservation score of predicted 
defected proteins. 
The lowest blast similarity is set to be the lower value of identity and coverage 
generated by BLAST. Samples are scattered horizontally showing that the correlation 
of scores generated by these two methods is not strong in this group. However, when 
threshold (0.75) is applied, 75% of the predictions are agreed by both methods. 
 
 
Samples getting different results from BLAST and our models were investigated in detail. 
Although significant difference is presented between predicted defected CHO proteins and 
their mouse homologs, some mouse sequences were matched to CHO sequences in the 
defected group with identity and coverage both higher than 90%. Meanwhile the identity and 
coverage generated from BLAST could be very low for some of the sequences in the intact 
group. By checking the alignments and site preservation of subfamilies yielding negative 
prediction on high similarity alignment issued by BLAST, the cause of such disagreement was 
that the highly similar fragmented proteins were found on both mouse and CHO protein 
selection. Due to splicing, shorter versions of protein may be annotated as an individual 
protein and could be used as a representative of the subfamily for BLAST verification as we 
randomly select mouse homolog from the subfamily. All the HMMs built in this project were 
designed to model full length of the protein and that was also used in proportion calculation 
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for high preservation sites. Containing only the fragmented version could suggest loss of 
sequence parts or incorrect gene boundary in annotation. On the other hand, positive 
predictions could result in low identity and coverage in BLAST due to incorrect alignments 
created by BLAST. In most of these cases, the sequences of the subfamily contain two or more 
similar regions. BLAST mismatched these regions when attending local optimum, which lead 
to short alignments in the final result. In our models, alignments were created by MAFFT 
which is more accurate in making alignments than BLAST. 
 
 
5.3 Expression and Prediction Correlation  
 
Unlike human proteins, considering disease-related variants to be deleterious may not be 
applicable to CHO. However, we hypothesised that variants affecting protein function, even 
only changing the efficacy, in highly expressed genes would bring significant deleterious effect 
to the cell which would then lead to extinction of cells carrying these variants. As a result, 
highly expressed genes are more conserved, or in other words deleterious mutation proof. 
Based on such hypothesis, we investigated the relation between expression and sequential 
preservation. CHO expression data were obtained from NCBI GEO. Two sets of expression 
data based on RNA-Seq from van Wijk et al. (2017) and Lee et al. (2016) respectively were 
selected. In their results, the abundance of expression is presented as Fragments Per Kilobase 
of transcript per Million mapped reads, also known as FPKM value, and the gene ids are 
presented with gene names. To map subfamilies onto gene names, we used gene names from 
mouse homologs within the subfamily. When multiple mouse homolog were available within 
one subfamily, the gene name used by most was used to represent the subfamily. Gene 
names from human homologs were applied when mouse homologs were not available. Two 
replicas are reported for every sample in their data and we first average the FPKM values of 
the replicas as the abundance of the gene expression for the corresponding sample, then the 
maximum abundance was used to map with the sequential preservation. In our hypothesis, 
deleterious effects come from the cost of synthesising biomass required to fulfil sufficient 
protein efficacy. Such cost is high when synthesising large amounts of biomass regardless of 
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the growing phase the cells are experiencing. Therefore, we did not select data on specific 
phase but adopted maximum expression measured in these researches.  
After the connection between FPKM value and sequential preservation via gene names, the 
genes were divided into five groups according to their maximum expression abundance. 
Genes with no expression detected in the involved researches were assigned to the same 
group which was excluded from the preservation distribution analysis. No expression 
detected in these researches indicates that these genes are likely expressed in a very low level 
which may largely increase in certain situations. Although a large proportion of genes fall into 
this category, as no evidence suggests the maximum expression of these genes, our 
hypothesis is not applicable to them leading to their removal from the related analysis. The 
rest of the genes with non-zero FPKM value were assigned to four groups whose range of 
FPKM value containing are shown in Table 5.3. Then the preservation distribution was plotted 
against the number of genes. The overall preservation distribution of all genes was used as a 
reference distribution which was then imported to the t-test with the distribution of different 
groups to evaluate the significance of being different. The significance level was set on two-
tail p-value. The sequential preservation profiles of gene of different expression level are 
shown in Table 5.3. It can be observed that the number of genes significantly decrease with 
expression level and 65.5% of the genes involved express in the lowest level (<50 FPKM). On 
the other hand, apart from genes not covered by preservation models, gene numbers 
increase with the level of preservation and 64.8% of these genes have preservation score 
higher than 0.9. Genes of different expression level present similar trend but t-test show that 
preservation profile of every expression level is significantly different (in a level of 0.01) with 
the general profile.  
The mean and variance of preservation in every expression level were investigated in Figure 
2.1Figure 5.3. This shows that the mean preservation increases with the level of expression 
in the groups where FPKM value are lower than 5000, and a subtle decrease is observed in 
the last group. Meanwhile, the variance decreases with the increase of mean preservation. 
Such a result is consistent with our hypothesis showing a high preservation on genes with 
high expression. However, it needs to be clarified that such a result only provides statistic 
support for our hypothesis so it could be wrong for some individual genes. Therefore, it can 
only be considered as a general trend in the genome level. 
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Table 5.3 Sequential preservation profile of genes of different expression levels. 
The expression levels are defined according to the FPKM value. The first level was 
defined as less than 50 and the following levels were defined with the increase of 
magnitude until the FPKM value reaches 5000. Total number of gene with sequential 
preservation level are presented to provide general preservation profile. T-test was 
performed for preservation profile of every expression level against the general 
profile and the results, including two-tail p-value, mean and variance, obtained are 
shown at the bottom. 
Preservation Overall gene [0-50) [50-500) [500-5000) >=5000 
0.0 2541 1864 472 190 15 
0.0-0.1 3 2 1 0 0 
0.1-0.2 8 7 0 1 0 
0.2-0.3 23 17 6 0 0 
0.3-0.4 54 38 11 4 1 
0.4-0.5 108 77 22 9 0 
0.5-0.6 177 140 28 6 3 
0.6-0.7 246 184 45 16 1 
0.7-0.8 404 298 68 36 2 
0.8-0.9 764 544 143 73 4 
>0.9 7956 4875 1707 1284 90 
total 12284 8046 2503 1619 116 
P-value  1.324E-07 0.00521197 3.7348E-34 0.0040362 
mean 0.73 0.70 0.76 0.84 0.83 
variance 0.153 0.163 0.145 0.101 0.113 
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Figure 5.3 The mean and variance of sequential preservation in different expression 
levels divided by FPKM value. 
Genes are classified by their expression levels according the FPKM values, and the 
corresponding means are presented with variance as error bars. Overall increase of 
mean preservation with expression level can be observed. 
 
 
5.4 Comparison of Predictions of Different CHO Related Genomes 
 
To identify the projection of subfamily prediction in the multi-gene function level, we 
compared prediction results of three CHO related genomes and mapped them onto GO using 
analysis tools available on the PANTHER website.  
To identify the character of the three CHO related genomes, the number of subfamily issuing 
abnormal predictions were compared. As mentioned previously, the CHO-K1 protein set is 
closed to the Chinese hamster in terms of number of different type of predictions. In this 
comparison (Table 5.4), the same features were observed. The number of subfamily making 
abnormal prediction for each genome is shown in the diagonal line. The number of shared 
subfamily are reported on the upper right corner. It shows that most of the abnormal 
predictions shared by more than one genome and, similar to the previous result, CHO-K1 and 
Chinese hamster shared most of such predictions. Apart from the potential cause of 
annotation pipeline difference which is mentioned previously, it could also be evidence of 
CHO-K1GS having been significantly evolved during screening and the culture process so that 
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the genetic distance between CHO-K1GS and CHO-K1 is actually larger than that between 
CHO-K1 and the Chinese Hamster sequenced. We further found that most subfamilies with 
abnormal predictions shared by CHO-K1GS and either of the other two genomes are actually 
shared by all three CHO related genomes. The number of such subfamily was 2,285. With the 
doubt that these subfamilies may issue abnormal predictions due to model overfitting, we 
compared them with subfamilies reported abnormality for rat and rhesus protein in validation. 
As a result, 1,427 subfamilies were reporting abnormal results for all five genomes.  
 
Table 5.4 Number of common subfamily reporting abnormal result 
 Chinese hamster CHO-K1 CHO-K1GS 
Chinese hamster 3,534 2,834 2,362 
CHO-K1  3,837 2,429 
CHO-K1GS   3,051 
 
The behaviour of these subfamilies could be due to improper selection of homologs or 
inherently low conservation within the family. To identify how these subfamilies would affect 
our later functional analysis with GO, they were mapped onto GO to identify terms these 
subfamilies cluster to. Since a different version (version 13.0) of PANTHER subfamily 
annotation was used by the online tool, direct mapping with subfamily ids would lead to 
substantial loss of mapped ids. The subfamilies were represented by gene names as they were 
mapped with the expression abundance. The list of representative gene names was uploaded 
to the website and overrepresentation test was performed with a list of gene names 
representing all subfamilies as reference using binomial model without Bonferroni correction. 
The PANTHER GO-slim for biological process was selected for the analysis. Such setting was 
carried on for all GO mapping of overrepresentation tests. The ten GO terms with lowest p-
value are presented in Table 5.5 as examples of the result (more results available in 
supplement 7). With GO terms in the first column, the numbers of related protein in the 
reference are shown in the second column. Then the number of protein related in query sets 
and the expected number in the query set calculated by binomial model are presented. The 
Table 5.5 was sorted by p-values in the last column. In general, the representative genes 
converged into GO terms of multi-cellular functions or even higher level functions such as 
sensory perception. The only term shown mainly related to single cell function was G-protein 
coupled receptor signalling pathway. However, GO terms with highest statistical significance 
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often relate to a large amount of genes which makes it difficult to extract the details. However, 
these subfamilies being less related to terms of single cell biological process would be 
beneficial for analyses related to CHO cells.  
 
Table 5.5 GO mapping for common altered functions 
PANTHER GO-Slim 
Biological Process 
Total 
proteins 
Query 
proteins 
Expected 
number 
over/under-
represent 
fold 
Enrichment 
P-value 
sensory perception 823 108 48.62 + 2.22 2.87E-14 
sensory perception of 
chemical stimulus 
684 92 40.41 + 2.28 7.05E-13 
sensory perception of 
smell 
638 86 37.69 + 2.28 3.70E-12 
neurological system 
process 
1316 131 77.75 + 1.68 5.67E-09 
system process 1408 136 83.18 + 1.63 1.69E-08 
G-protein coupled 
receptor signaling 
pathway 
793 86 46.85 + 1.84 9.13E-08 
biological regulation 3424 263 202.28 + 1.3 2.90E-06 
single-multicellular 
organism process 
1979 165 116.92 + 1.41 4.76E-06 
multicellular organismal 
process 
1994 166 117.8 + 1.41 4.82E-06 
cellular process 8073 549 476.94 + 1.15 7.54E-06 
 
The functions predicted to be altered in all CHO related genomes excluding those in rat and 
rhesus were then mapped onto the same GO slim (Table 5.8). 862 subfamilies fell into this 
category and were mapped onto GO. Compared to the mapping with common altered 
functions in rat and rhesus included (Table 5.6), terms describing cellular processes, such as 
receptor signalling pathways, were more statistically significant. However, comparing terms 
associated with altered function specific in CHO related genomes (Table 5.8) and those shared 
by rat and rhesus (Table 5.7), 5 general terms are shared by their top list, which could be 
caused by the bias on large numbers in statistical tests. We also found that, by removing 
subfamilies predicting altered in rat and rhesus, specific GO terms with the number of gene 
manageable for manual inspection moved up on the list sorted by p-value. This suggests genes 
contained by these subfamilies are only related to general terms due to the lack of detailed 
knowledge. This highlighted the fact that the annotation level of individual genes could be the 
main restriction of making use of our model prediction, given the predictions were accurate. 
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Table 5.6 GO mapping of altered function shared by CHO related genomes 
PANTHER GO-Slim 
Biological Process 
Total 
proteins 
Query 
proteins 
Expected 
number 
over/under-
represent 
fold 
Enrichment 
P-value 
sensory perception of 
chemical stimulus 
684 158 58.26 + 2.71 1.32E-28 
sensory perception 823 175 70.09 + 2.5 1.32E-27 
sensory perception of smell 638 139 54.34 + 2.56 6.08E-23 
G-protein coupled receptor 
signalling pathway 
793 154 67.54 + 2.28 1.25E-20 
neurological system process 1316 202 112.08 + 1.8 9.08E-16 
biological regulation 3424 418 291.62 + 1.43 3.58E-15 
system process 1408 207 119.92 + 1.73 2.58E-14 
response to stimulus 3097 376 263.77 + 1.43 3.50E-13 
regulation of biological 
process 
2898 356 246.82 + 1.44 4.21E-13 
single-multicellular 
organism process 
1979 259 168.55 + 1.54 3.31E-12 
 
 
Table 5.7 GO mapping of altered function shared by CHO related genomes, rat and rhesus 
PANTHER GO-Slim 
Biological Process 
Total 
proteins 
Query 
proteins 
Expected 
number 
over/under-
represent 
fold 
Enrichment 
P-value 
sensory perception 823 108 48.62 + 2.22 2.87E-14 
sensory perception of 
chemical stimulus 
684 92 40.41 + 2.28 7.05E-13 
sensory perception of smell 638 86 37.69 + 2.28 3.70E-12 
neurological system process 1316 131 77.75 + 1.68 5.67E-09 
system process 1408 136 83.18 + 1.63 1.69E-08 
G-protein coupled receptor 
signalling pathway 
793 86 46.85 + 1.84 9.13E-08 
biological regulation 3424 263 202.28 + 1.3 2.90E-06 
single-multicellular 
organism process 
1979 165 116.92 + 1.41 4.76E-06 
multicellular organismal 
process 
1994 166 117.8 + 1.41 4.82E-06 
cellular process 8073 549 476.94 + 1.15 7.54E-06 
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Table 5.8 GO mapping for altered proteins common in CHO related genomes but normal in 
rat and rhesus 
PANTHER GO-Slim 
Biological Process 
Total 
proteins 
Query 
proteins 
Expected 
number 
over/under-
represent 
fold 
Enrichment 
P-value 
sensory perception of 
chemical stimulus 
684 66 18.47 + 3.57 8.67E-19 
G-protein coupled receptor 
signalling pathway 
793 68 21.41 + 3.18 9.03E-17 
sensory perception 823 67 22.22 + 3.02 1.87E-15 
response to stimulus 3097 153 83.62 + 1.83 1.60E-14 
sensory perception of smell 638 53 17.23 + 3.08 9.91E-13 
biological regulation 3424 156 92.45 + 1.69 6.14E-12 
regulation of biological 
process 
2898 134 78.24 + 1.71 1.42E-10 
multi-multicellular organism 
process 
26 11 0.7 + 15.67 2.44E-10 
mammary gland 
development 
26 11 0.7 + 15.67 2.44E-10 
cell surface receptor 
signalling pathway 
1448 81 39.1 + 2.07 4.54E-10 
 
To investigate the difference between CHO and Chinese hamster, functions predicted altered 
in CHO-K1 and CHO-K1GS but normal for Chinese hamster were analysed (Table 5.9). Only 
124 subfamilies belong to this category and all the GO terms with a p-value lower than 0.05 
were presented in Table 5.9. Unlike the previous mapping result, these subfamilies were more 
related to specific functions while showing negative enrichment on high level general 
functions such as biological regulation and sensory perception. Although the number of 
subfamilies were low and not many terms enriched significantly, interesting terms, such as 
protein folding, fatty acid metabolic process and lipid metabolic processes, are presented.  
 
 
 
Table 5.9 GO mapping of altered functions common in CHO-K1 and CHO-K1GS but normal 
in Chinese hamster 
PANTHER GO-Slim 
Biological Process 
Total 
proteins 
Query 
proteins 
Expected 
number 
over/under-
represent 
fold 
Enrichment 
P-value 
disaccharide metabolic 
process 
2 1 0.01 + 88.23 1.13E-02 
fatty acid beta-oxidation 21 2 0.12 + 16.81 6.49E-03 
protein folding 83 3 0.47 + 6.38 1.20E-02 
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fatty acid metabolic 
process 
168 5 0.95 + 5.25 2.80E-03 
lipid metabolic process 407 6 2.31 + 2.6 2.87E-02 
cell adhesion 350 5 1.98 + 2.52 4.95E-02 
biological adhesion 350 5 1.98 + 2.52 4.95E-02 
biological regulation 3424 12 19.4 - 0.62 3.59E-02 
response to stimulus 3097 10 17.55 - 0.57 2.67E-02 
nucleobase-containing 
compound metabolic 
process 
2549 7 14.45 - 0.48 1.79E-02 
sensory perception 823 1 4.66 - 0.21 4.99E-02 
RNA metabolic process 1417 1 8.03 - 0.12 2.29E-03 
 
The difference between CHO-K1 and CHO-K1GS was compared by inspecting altered function 
in either genome but not in the Chinese hamster genome (Table 5.10 and Table 5.11). When 
comparing these two CHO genomes, we assumed CHO-K1GS a descendent of CHO-K1 
although in comparison of the two cell lines the inheritance direction only affects the 
hypotheses and interpretation of the result but not the result itself. Under such assumption, 
CHO-K1GS appeared to be more adapted to the suspension culture environment since more 
adhesion related functions are altered in CHO-K1GS while alteration in CHO-K1 still lingering 
on general terms (this could be the annotation problem however).  
 
Table 5.10 GO mapping for proteins altered in CHO-K1 but normal in Chinese hamster 
PANTHER GO-Slim 
Biological Process 
Total 
proteins 
Query 
proteins 
Expected 
number 
over/under-
represent 
fold 
Enrichment 
P-value 
sensory perception of 
smell 
638 2 24.63 - 0.08 4.60E-09 
sensory perception of 
chemical stimulus 
684 3 26.4 - 0.11 7.95E-09 
sensory perception 823 7 31.77 - 0.22 8.42E-08 
G-protein coupled 
receptor signalling 
pathway 
793 7 30.61 - 0.23 2.17E-07 
mesoderm development 262 24 10.11 + 2.37 1.24E-04 
response to stimulus 3097 87 119.55 - 0.73 4.37E-04 
developmental process 1476 80 56.98 + 1.4 1.51E-03 
neurological system 
process 
1316 32 50.8 - 0.63 2.43E-03 
cell surface receptor 
signalling pathway 
1448 37 55.89 - 0.66 3.56E-03 
blood circulation 19 4 0.73 + 5.45 6.72E-03 
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Table 5.11 GO mapping for proteins altered in CHO-K1GS but normal in Chinese hamster 
PANTHER GO-Slim 
Biological Process 
Total 
proteins 
Query 
proteins 
Expected 
number 
over/under-
represent 
fold 
Enrichment 
P-value 
cell adhesion 350 18 5.91 + 3.04 3.78E-05 
biological adhesion 350 18 5.91 + 3.04 3.78E-05 
heart development 20 4 0.34 + 11.84 4.09E-04 
metabolic process 5470 67 92.41 - 0.72 7.68E-04 
response to stimulus 3097 32 52.32 - 0.61 7.71E-04 
cell-cell signalling 571 21 9.65 + 2.18 8.43E-04 
muscle organ 
development 
27 4 0.46 + 8.77 1.24E-03 
neurological system 
process 
1316 10 22.23 - 0.45 2.38E-03 
G-protein coupled 
receptor signalling 
pathway 
793 4 13.4 - 0.3 2.42E-03 
sensory perception of 
chemical stimulus 
684 3 11.56 - 0.26 2.85E-03 
 
 
 
5.5 Summary 
In this chapter, protein sequences of three CHO related genomes were analysed by our 
pipeline. The predictions were verified against a widely used tool BLAST and our pipeline 
showed better accuracy in results disagreed by BLAST. Although only part of normal and 
defected predictions were verified, it suggests a high precision of these two types of 
predictions. We then related the gene preservation with expression which showed significant 
correlation as expected. However, when comparing predictions between three CHO related 
genomes, unexpected similarity between CHO-K1 and Chinese hamsters suggest the genetic 
distance between CHO-K1 and CHO-K1GS is further than that to Chinese hamster, but the 
difference of annotations toward the same assembly from different source was also 
concerning. The model predictions were intensively mapped on GO. Although most of the 
terms suggested by statistical significance were related to many genes, interesting terms with 
manually manageable number of genes were suggested which may motivate further research 
in greater detail in the future. 
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6 Case Studies and Hypotheses 
Several cases were selected to be inspected in greater detail in this chapter. Firstly, the 
mutation on TP53, a marker gene for cancer cell lines. Secondly, some unexpected alterations 
on proteins related to glycolysis identified in the results described in chapter 5. After that, 
some pathways had been extensively studied on CHO or other cancer cell lines were studied 
in detail. As only general terms with large number of genes presented in the GO mapping 
reported in chapter 5, the mapped genes are mostly scattered and not well annotated. We 
could not choose cases from those results. 
  
6.1 Mutations on TP53 
TP53 is a well-known cancer suppressor whose mutation is observed in all types of cancer. It 
is possible that CHO cell lines share such feature. Therefore, we investigated prediction of 
TP53 in all three CHO related genomes. Unexpectedly, both our HMM and preservation model 
predicted TP53 being normal in CHO-K1 and CHO-K1GS, but altered in Chinese hamster. The 
matched sequence id and sequential preservation are shown in Table 6.1. We then BLAST the 
mouse version of TP53 against Chinese hamster related RefSeq data. The BLAST result (Table 
6.2) confirmed our predictions. The TP53 homolog in CHO-K1 scores higher in not only bit 
score, but also in query cover and percentage of identity than the homolog in Chinese hamster. 
Our sequential preservation analysis showed that 10% of sites with preservation level higher 
than 3.8 mutated from their preserved residues in CHO-K1 and CHO-K1GS, while the 
proportion for Chinese hamster homolog is 48% (supplement 8 and 9). Such unexpected 
mutation on Chinese hamster homolog could be caused by incorrect assembly or annotation. 
Details of homologs from CHO-K1 and CHO-K1GS were further inspected. Our annotated 
preservation maps of all sites of the matched sequence (supplement 10 and 11) addressed 
multiple high preservation sites responsible for DNA binding mutated from the most 
preserved residues in both CHO-K1 and CHO-K1GS, suggesting alteration in protein function. 
As we used a fairly arbitrary threshold of 0.75 on prediction using sequential preservation, 
this result indicated that this threshold used could be too conserved to miss the true negatives. 
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Table 6.1 TP53 preservation in CHO related genomes 
 Chinese hamster CHO-K1 CHO-K1GS 
Sequence id XP_007606822 NP_001230905 ENSCGRP00001011268 
Sequential 
preservation 
0.52 0.90 0.90 
 
Table 6.2 BLAST result of TP53 in CHO genome from NCBI 
Description 
Max 
score  
Total 
score 
Query 
cover  
E 
value  
Ident Accession 
cellular tumor 
antigen p53  
603 603 100% 0.0 76% NP_001230905.1 
PREDICTED: tumor 
protein 63 isoform 
X3  
270 270 72% 3e-86 49% XP_003495647.1 
PREDICTED: tumor 
protein p73 isoform 
X4  
271 271 85% 2e-85 44% XP_007606822.2 
PREDICTED: tumor 
protein 63 isoform 
X2  
268 268 72% 2e-85 49% XP_007640645.1 
PREDICTED: tumor 
protein p73 isoform 
X2  
270 270 85% 2e-84 44% XP_007606823.2 
PREDICTED: tumor 
protein p73 isoform 
X1  
269 269 66% 4e-84 50% XP_016818894.1 
PREDICTED: tumor 
protein p73 isoform 
X3  
269 269 85% 5e-84 44% XP_007606821.2 
PREDICTED: tumor 
protein 63 isoform 
X1  
268 268 72% 2e-83 49% XP_003495644.1 
 
 
6.2 Glycolytic Process 
 
Glycolytic process is the core metabolic process providing energy for cell activities and 
precursors for amino acid synthesis. It is conserved across species in different kingdoms and 
therefore CHO-K1 was not expected to be an exception. However, the subfamilies reporting 
abnormal result in all validating and query genomes contained 6 (out of 26 were modelled) 
gene involved in the glycolysis. Although all of these results were believed to be false and the 
corresponding subfamilies were excluded by later analyses, we examined these 6 false 
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negative results for cause of false prediction. We found that all 6 negative results were issued 
by HMMs. The corresponding sequential preservation calculated on CHO-K1 proteins and FMI 
for HMMs were shown in the Table 6.3. As a threshold of 0.75 was applied to sequential 
preservation for prediction, all of these genes were predicted normal by the preservation 
model. However, only a spliced version of ENO1 was found on CHO-K1 proteins, resulting in 
a lower preservation ratio. Moreover, FMI of most corresponding HMM are lower than 0.7. 
Only HMM with FMI higher than 0.7 could issue defected predictions, however, any HMM 
could issue prediction of altered. According to the model performance on these 6 genes, 
sequential preservation appeared to be a more reliable metric for making predictions and 
HMMs predictions must be considered with its quality metrics to avoid false results. 
 
Table 6.3 Details of prediction results for 6 glycolysis related genes 
Gene name Subfamily id 
Sequential 
preservation 
FMI 
HK1 PTHR19443SF36 0.94 0.62 
PGK2 PTHR11406SF21 0.97 0.79 
PGK1 PTHR11406SF20 0.99 0.63 
PFKFB2 PTHR10606SF59 0.94 0.65 
ENO1 PTHR11902SF26 0.77 0.61 
LDHA PTHR43128SF4 0.99 0.54 
 
Other results presented previously are worth mentioning as another energy related core 
process of fatty acid beta-oxidation appeared in mapping altered functions shared by two 
CHO-K1 genomes but not Chinese hamster. The reason this term appeared is the subfamily 
containing ACAA1 homologs issued abnormal prediction. This protein was not preserved 
enough for sequential preservation calculation and the HMM responsible has a FMI value of 
only 0.62. Therefore, this prediction is likely to be false and more importantly, the both forms 
in mouse ACAA1A and ACAA1B which were modelled by other subfamilies were predicted 
normal, indicating this process is not affected by mutations. 
 
6.3 Apoptosis 
 
Apoptosis is a process with many tumour related genes such as BCL2 and BAK. It has been 
extensively studied in CHO cell for prolonging cell life span and improving productivity. Lewis 
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et al. (2013) identified 101 anti- and pro-apoptosis proteins making up to 82 genes after 
merging the variant of the same gene. 39 of them were modelled and had their names 
mapped with the subfamilies in this project while others may be named differently or missed 
by the homolog collection. Consistent with Lewis et al. (2013), most of these genes were 
predicted normal by our models and only 4 had found to be altered in related CHO cell (Table 
6.4). Of these 4 genes, only CIDEC were predicted to be altered in both CHO-K1 and CHO-K1GS 
while others, DFFA, NFKB1 and ATM were only predicted altered in CHO-K1. They also 
reported another 4 genes: CASP10, IL3RA, IL3 and IL1A to be missing in CHO related genomes. 
Our models agreed with most of these results except IL1A which was found in all three CHO 
related genomes with high confidence. 
 
Table 6.4 Predictions on apoptosis related genes 
 
 
We further mapped the related predictions onto KEGG apoptosis pathway (Figure 6.1). All of 
the proteins in the pathway were predicted normal (marked with blue in the figure). However, 
detailed inspection on alignment of BCL2 from CHO-K1 and CHO-K1GS shows significant 
difference. BCL2 is strongly related to breast cancer so that it is used as one of the markers in 
diagnosis and treatment for related cancers. BCL2 was found to be overexpressed in most 
breast cancer cells. While BCL2 in CHO-K1GS is highly conserved to the BCL2 isoform alpha in 
mouse and human, the CHO-K1 version of BCL2 was found to be more close to the isoform 
beta which is about 35 residues shorter. However, the 3’ end sequence of BCL2 in CHO-K1 is 
not similar to that of isoform beta in mouse and human. Both homologs from CHO-K1 and 
CHO-K1GS are highly preserved on annotated function sites. For now, no evidence has 
suggested difference in function of the different isoforms. Another protein that attracted our 
attention was CASP9. Its homolog in CHO-K1 was found to be high conserved with that in 
Category  Normal  Altered or defected 
Anti-apoptosis TRAF2, OPTN, MYD88, CFLAR, BIRC7, 
BIRC3, AKT2, RIPK1, AKT1, XIAP, AKT3, 
IRAK1, IRAK2, IRAK3, PRKX, IRAK4, BCL2 
DFFA, NFKB1, CIDEC 
Pro-apoptosis CASP6, CASP7, AIFM1, CASP3, BID, CHP1, 
TRADD, CASP9, CIB1, BAX, FADD, CASP8, 
CHP2, DFFB 
ATM 
Receptor  NTRK1, IL1R1  
Ligand IL1B, NGF  
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mouse. However, the CASP9 in CHO-K1GS was significantly less conserved and only 75% of its 
high preservation sites remain preserved. More importantly, one of its two active site 
annotated was found to be mutated suggesting significant alteration in protein function. 
However, such mutation could be the result of screening for high viability. 
 
 
 
 
Figure 6.1 KEGG pathway of apoptosis. 
All proteins included by the pathway were predicted normal in CHO related genomes. 
 
 
 
 
6.4 DNA repairing 
DNA repairing is also an essential process for maintaining genetic information within the cell. 
Defects or alterations in the process could lead to increase of the mutation rate and genetic 
instability. Therefore, cancer cell lines, which feature high mutation rate and chromosome 
instability, may adopt mutations on the related genes. However, as production cell lines, 
adopting these mutations could affect the stability of transfected sequences which reduce 
the productivity. As the related GO terms contain many repetition of annotations from 
various contributors, we adopted a gene selection commonly used in array analyses from 
QIAGEN website. It contains a total of 84 related genes categorised into five classes: Base 
Excision Repair (BER), Base Excision Repair (NER), Mismatch repair, Double-strand break 
repair and others. One of the genes involved, POLD3, was not modelled in this project. Our 
models predicted most of these genes to be normal in both CHO-K1 and CHO-K1GS, except 
Xpa, Xrcc5, Atm and Mgmt (Error! Not a valid bookmark self-reference.), of which Mgmt was 
actually predicted normal in CHO-K1GS and Chinese hamster but altered in CHO-K1. It shows 
85 
 
that mismatch repair and BER are perfectly conserved and only a few genes in NER and 
double-strand break repair presented evidence of significant alterations in at least one CHO 
cell line. 
 
Table 6.5 Predictions on DNA repair related genes 
 
 
Category  Normal  Altered or defected 
Base Excision Repair  Apex1, Apex2, Ccno, Lig3, 
Mpg, Mutyh, Neil1, Neil2, 
Neil3, Nthl1, Ogg1, Parp1, 
Parp2, Parp3, Polb, Smug1, 
Ung, Tdg, Xrcc1 
 
Nucleotide Excision Repair Atxn3, Brip1, Ccnh, Cdk7, 
Ddb1, Ddb2, Ercc1, Ercc2, 
Ercc3, Ercc4, Ercc5, Ercc6, 
Ercc8, Lig1, Mms19, Pnkp, 
Poll, Rad23a, Rad23b, Rpa1, 
Rpa3, Slk, Xab2, Xpc 
Xpa 
Mismatch Repair Mlh1, Mlh3, Msh2, Msh3, 
Msh4, Msh5, Msh6, Pms1, 
Pms2, Trex1 
 
Double-Strand Break Repair Brca1, Brca2, Dmc1, Fen1, 
Lig4, Mre11a, Prkdc, Rad21, 
Rad50, Rad51, Rad51c, 
Rad51b, Rad51d, Rad52, 
Rad54l, Xrcc2, Xrcc3, Xrcc4, 
Xrcc6 
Xrcc5 
Other Genes Related to DNA 
Repair 
Atr, Exo1, Rad18, Rfc1, 
Top3a, Top3b, Xrcc6bp1 
Atm, Mgmt 
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Figure 6.2 KEGG pathway of mismatch repair. 
Related proteins were all predicted normal in this pathway in CHO related genomes. 
 
Since pathways of the four different DNA repairing mechanisms were available on KEGG 
pathway, we further examined the details of these pathways. Most genes are shared by the 
array selection and pathway. Mapping of the mismatch repair pathway and the array both 
show perfectly normal in all genes despite the gene involved was quite different (Figure 6.2). 
In the NER pathway (Figure 6.3), TTDA was not covered by our models and, consistent with 
predictions on array selection, only XPA was considered altered. Such alteration was only 
observed in CHO-K1 and unexpectedly Chinese hamster while the CHO-K1GS homolog was 
highly conserved with the mouse homolog.  
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Figure 6.3 KEGG pathway of NER. 
The protein in the red box, TTDA, was not covered by the models. The protein in the 
white box, XPA, was predicted altered or defected in at least one CHO related 
genomes. 
 
No significant alteration was observed in the other pathways. In the long patch BER pathway 
(Figure 6.4), gene Mug was predicted to be altered in all three genomes by HMMs with high 
FMI. The corresponding alignment showed no full length protein found on these genomes, 
although the fragmented proteins were highly similar to the related part of sequences from 
other species, suggesting they could be active spliced proteins of the gene. The only two genes 
reported not normal in double-strand break repair were SYCP3 and BLM (Figure 6.5). However, 
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the subfamily related to SYCP3 contain only human sequences and thus was not reliable. On 
the other hand, CHO-K1 homolog of BLM was predicted to be altered as it is significantly 
shorter than homologs even in CHO-K1GS and Chinese Hamster which were predicted to be 
normal.  
 
 
Figure 6.4 KEGG pathway of BER. 
The pathway includes short patch and long patch BER and BER complex. Only one 
related protein, Mug in the white box, was predicted abnormal in at least one of CHO 
related genomes. 
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Figure 6.5 KEGG pathway of double-strand break repair. 
Two mechanisms, homologous recombination and non-homologous end-joining, are 
included by the pathway. One protein, DSS1 in the red box, was not included by the 
models. Two proteins related to homologous recombination pathway, SYCP3 and 
BLM in white boxes, were predicted abnormal in at least one of the CHO related 
genomes. 
 
Although only a few genes appeared to be affected by mutations, their homologs in CHO-
K1GS are constantly more close to their wildtype compared to CHO-K1. This indicates CHO-
K1GS could be a more stable cell line for production. 
 
6.5 Protein Glycosylation 
 
In simple words, glycosylation is a co-translational PTM that adds specific oligosaccharides to 
proteins. It can be so widely observed in nature that, according to Apweiler (1999), half of the 
proteins known are glycosylated. For mAbs, one of the main biopharmaceutical products 
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manufactured using CHO, glycosylation is crucial for their efficacy: on Fab, glycosylation can 
affect the affinity to target antigen while on Fc, glycosylation affects the efficiency of binding 
the cell receptor and triggering downstream immune activities, such as antibody-dependant 
cellular cytotoxicity (ADCC) and complement-dependant cytotoxicity (CDC) (Jefferis, 2005a). 
Moreover, improper glycosylation can trigger an immune reaction against mAbs themselves. 
However, the glycosylation profile is highly species-specific and acts as a marker that 
distinguishes self-bodies from foreign bodies. Therefore, manufacturing mAbs requires the 
host cell to be able to glycosylate proteins in a human-compatible manner. Although CHO 
cells are popular as a manufacturing platform, as rodent origin cell lines, further genetic 
modifications are still required to improve product efficacy.  
 
 
Figure 6.6 Species specific N-glycosylation on Asn. 
Different glycosylation of Asn in human, CHO and mouse is compared. (Beck et al., 
2008; Jefferis, 2005a) 
 
In mAb IgG, glycosylation can occur at both ends of the residue but the N-glycosylation on the 
asparagine (Asn) residue is most studied. The Fc region is glycosylated at Asn-297 while 
multiple sites in the Fab region can be glycosylated, resulting in higher heterogeneity of the 
IgG glycoform (Jefferis, 2005b). The pathway responsible is shown in Figure 6.7 (Johnson et 
al., 2014). CHO is able to glycosylate Asn-297 in a slightly different way from humans and mice, 
as shown in Figure 6.6 (Jefferis 2005 and Beck et al. 2008). Although they all share the same 
core structure, a series of genetic engineering had been conducted on CHO. CHO originally 
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does not produce bisecting GlcNAc as human, and does not normally express ST6Gal activity 
to link sialic acid to galactose (Xu et al., 2011; Beck et al., 2008). This fact was confirmed by 
our models that the protein responsible for these processes, MGAT3 and ST6GAL1, were 
detected defeated in Chinese hamster genome. In order to improve the ADCC of product 
mAbs, GnTIII (MGAT3) was transfected into CHO to produce the bisecting GlcNAc branch 
(Umaña et al., 1999), while FUT8, which is responsible for adding fucose to the 
oligosaccharide, was knocked out for higher efficacy (Yamane-Ohnuki et al., 2004). Our 
models showed that although being predicted defect in Chinese hamster, MGAT3 and 
ST6GAL1 were predicted normal in CHO-K1 and CHO-K1GS, while another protein responsible 
for ST6GAL activity, ST6GAL1 was found normal in all three CHO related genomes. However, 
in the CHO-K1 genomes we examined, FUT8 was not knocked out and remained normal. 
Another critical gene in the pathway, MGAT1 was reported to be altered by our models, but 
further inspection showed that it is a prediction issued by HMM with low FMI and our 
preservation model considered it normal. Therefore, it was marked normal as other proteins 
involved in the pathway. 
 
 
Figure 6.7 N-glycosylation pathway 
The pathway is adapted from Johnson et al (2014). All the related proteins were 
predicted normal in CHO related genomes. 
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Figure 6.8 KEGG pathway of glycosylation. 
Three proteins, ALG7, SIAT1 and SIAT2 marked by red boxes, were not covered by the models. 
Another three proteins, ALG13, ALG14 and MGAT5 in white boxes, were predicted altered or 
defected in at least one of CHO related genomes. 
 
 
A pathway containing former synthesis reaction was found in KEGG pathway showing more 
glycosylation related proteins (Figure 6.8). However, not all the proteins involved were 
covered by our models possibly due to lack of annotation. Proteins marked with red (ALG7, 
SIAT1 and SIAT2) were not covered by our models and thus no prediction was made on them. 
Proteins marked with blue were predicted normal in CHO-K1 and CHO-K1GS while those 
marked with white were predicted not normal in at least one of the CHO genomes. Xu et al. 
(2011) reported lack of ALG13 homolog in the CHO-K1 genome. However, our models 
predicted ALG13 to be normal in CHO-K1 but altered or defeated in CHO-K1GS and Chinese 
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hamster. Meanwhile, a similar protein ALG14 was found normal in both CHO-K1GS and 
Chinese hamster but predicted altered in CHO-K1. Other proteins involved were mostly found 
normal in this project except MGAT5 which was predicted altered in all three genomes. Our 
results were consistent with most of the public results and engineering outcome, suggesting 
that both CHO cell lines are able to produce human-compatible proteins. 
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7 Conclusion  
 
7.1 Result summary 
In this project, we constructed a tool for predicting protein function alteration based on 
phylogenetic preservation. The tool works on a two steps system: 1) identify best available 
protein sequences in the genome using HMMs which would issue a primary prediction of the 
function alteration on the protein; 2) then calculate the site preservation on every site of the 
matched sequence which would become the base of sequential preservation for final 
prediction. Validation by step showed that HMMs were capable of finding the correct best 
available sequence and assigning sequences to the correct subfamilies in high precision. 
However, the HMMs’ prediction of function impact based on sequence variants was not 
reliable on its own. In comparison, the preservation model was better in making such 
predictions. The validation shows our preservation model could produce results strongly 
correlating to the molecular age calculated by PANTHER-PSEP and the annotated function 
sites from uniprot. Moreover, in the validation with BLAST on selected CHO-K1 sequences, 
the normal and defected predictions made by our tool were mostly agreed by BLAST in terms 
of percentage of identity and alignment coverage. In comparison with gene expression data, 
our sequential preservation showed significant correlation with the maximum expression 
level. However, further comparison on predictions for different genomes showed that a small 
proportion of subfamily models are constantly making unreliable negative predictions. After 
removing these unreliable results, we still could not retrieve hypotheses specific enough to 
motivate further research on cell line development. The main reason was the biological 
processes that the hypotheses were built on were too general and involved too many genes 
so that could not provide clear directions for further research. In the case studies, we 
identified major source of false predictions of altered function being HMMs with low FMI, 
which stands for low accuracy in classifying proteins functions to be normal or not. Further 
investigation on pathways related to protein production showed that CHO-K1GS appear to be 
a better production cell line than CHO-K1, although the number of protein predicted to be 
different in function was not high between the two genomes.  
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7.2 Achievements and limitations 
We identified HMM for search homologous sequence and preservation model for potential 
function altering site from the related research. They both demonstrated good performance 
for the purpose assigned. However, an arbitrary threshold used for making prediction was not 
well supported and therefore resulted in questionable predictions in later analyses. 
Supportive evidence and assumptions are required for the better threshold to be made. A 
metrics FMI made for evaluating classification capacity of HMMs was only used for predictions 
of defected function but not altered function which lead to many false predictions. Involving 
the FMI in all HMM prediction should significantly improve the accuracy. However, it would 
lead to significant shrink in coverage as subfamilies close to each other would result in low 
FMI on each other in our pipelines. As a matter of fact, coverage has been a significant 
limitation for our tool. Firstly, both HMM and preservation model require good quality of 
homologous sequence collection. To achieve good performance, HMMs required clear 
grouping on the homologous sequence collection while preservation required involvement of 
many related species. Secondly, the main source of sequence collection, the PANTHER 
subfamilies, merely covered less than 10,000 families making up more than 19,000 
subfamilies in this project. Compared to the gene counts of more than 24,000 in annotations 
of mammalian genomes, such a number was insufficient. By the time this thesis was written, 
the number of family and subfamily included by PANTHER had been significantly improved. 
However, before proper investigation of the quality of new PANTHER subfamilies, it was not 
certain that they could improve the effective coverage of our models. The preservation model 
appeared to be promising in making predictions and identifying critical site mutations in the 
sequence given that most of the sites are conserved with the wildtype sequence. However, 
by definition of the PANTHER subfamily, it is normal that the preservation of some subfamilies 
is low. These subfamilies will never be covered by the preservation model unless we change 
the method of calculation. An option is to involve sequences within the same linage outside 
the subfamily. However, it would then conflict with the main objective of HMMs, which was 
identifying sequence between subfamilies.  
Although validation results showed our models were capable of making accurate predictions, 
we failed to extract practical hypotheses from the prediction. One of the causes for that is GO 
mapping and enrichment calculation. In this project, we used the most significantly enriched 
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GO terms for making hypotheses. However, the statistical significance always favours large 
number so that specific terms with lower number of related gene will rarely be ranked on top. 
In addition, as the enrichment was calculated against all the genes involved, the calculation 
for each GO term was independent. However, when comparing GO terms with such 
enrichment, as GO terms were designed to be overlapping with each other, the assumption 
of independent does not apply. Therefore, we suggest that using statistical significance as a 
filter to highlight enriched GO terms is effective, but further sorting GO terms with the 
significance may not reveal the true order of enrichment significance. Once a significant 
enriched GO term is identified, its daughter term should be investigated under the condition 
that their parents are enriched to some extent. However, if one uses a GO-slim with terms 
independent to each other, such sorting should be preferable. Another cause of failure in 
generating useful hypotheses was insufficient prediction accuracy which could be improved 
by the approaches mentioned in previous paragraphs. It is worth mentioning that inaccurate 
genome annotations could also be the cause. Some of the unexpected results raised our 
doubts toward the annotations. However, we do not have sufficient evidence showing the 
annotations are problematic, although improvement on the annotation is absolutely required 
for better outcome.   
 
7.3 Future works  
To accomplish our final goal to accurately predict function impact of variants in CHO proteins, 
further works could be focused on several aspects: 
 Further integration of HMM predictions and preservation using machine learning 
techniques. Using proper machine learning technique could assign optimised weights 
to the HMM result and preservation result for better integrative results. More 
features or metrics, such as expression level, can be added to the integration for better 
predictions. 
 Improving subfamily collection and annotation. In this project, we extended PANTHER 
subfamily using in silico approaches. However, for higher quality subfamily collection, 
human review and curation could be required. 
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 Customising production related GO slim on CHO. Creating GO slim on specified on CHO 
cell engineering could highlight terms related to protein production and allow useful 
hypotheses to be made given accurate function predictions. 
 Relating CHO phenotype information with sequence variant data. Achieving accurate 
function prediction relies on strong connection between phenotype and genotype. 
Therefore, coupling these two sets of data is highly necessary for further improvement 
of this project. Currently, data of CHO phenotype were rarely extracted with its gene 
profile but more with the parameters of culture environments. 
 Sequencing different CHO cell line for a better consensus CHO genome assembly and 
annotation. The quality of gene annotation for protein sequences is always a 
determinative factor for accurate prediction. Improvements of the CHO genome 
annotation has been constantly made by related institutes such as EBI and NCBI. 
However, we suggest greater improvement is acquired. 
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